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1Block, and Purcell discovered nuclear magnetic resonance (NMR) in 1946 
(Bloch, 1946; Purcell et al., 1946). Since then, NMR has made important 
contributions in physics, biology, chemistry, and medicine. Magnetic 
resonance spectroscopy (MRS) is one application of NMR, a widely used 
noninvasive technique to quantify the metabolic profiles of humans 
and animals. Proton (1H) MRS enables the detection of metabolites with 
hydrogen-containing compounds in the voxel, playing a pivotal role in 
clinical and neuroscientific research. 
This thesis aims to improve the sensitivity and reproducibility of acquisition 
for proton spectroscopy in the human brain. In particular, this work focuses 
on γ-aminobutyric acid (GABA) measurement and quantification using 
single-voxel spectroscopy (SVS) at 7 T. 
1.1 Nuclear magnetic resonance spectroscopy
NMR exploits the magnetic properties of nuclei. In a strong magnetic field 
(i.e., a B0 field), nuclei with non-zero spin quantum numbers will be 
distributed over various eigenstates according to the Boltzmann 
distribution (see Figure 1.1). Application of a radio-frequency (RF) pulse at 
the transition frequency will modify the relative population of the states, 
and in the appropriate circumstances, it can lead to the generation of 
transverse magnetization. NMR spectroscopy is based on the 
measurement of the electromotive force induced by the precession of 
the net magnetization according to Faraday’s law. The specific resonance 
frequency depends on the strength of the magnetic field and the 
magnetic properties of the chemical environment of the nuclei. The NMR 
response to an RF pulse (i.e., free induction decay (FID)) is recorded in the 
time domain. After Fourier transforming the FID, a series of peaks can be 
visualized in the frequency domain, which corresponds to nuclei rotating 
frequency along a chemical shift axis after Fourier transform. 
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Figure 1.1 Concept of Nuclear Magnetic Resonance (NMR).
In a strong static field, nuclei are aligned with the magnetic field (α-spin 
status) or against the magnetic field (β-spin status). This phenomenon is 
called the Zeeman effect (see Figure 1.2). The intrinsic frequency of the 
precession is the Larmor frequency       . The perturbation in the energy of 
the Zeeman state with magnetic quantum number  can be expressed as:
(1.1)
where  denotes the magnetic dipole moment,  is the static field 
strength,  is a gyro magnetic ratio, and is the Larmor frequency, 
Figure 1.2. Energy levels for a nucleus spin quantum number 1/2 under an applied magnetic 
field. 
For a spin ½ nucleus, the higher energy state (excited state) is defined as 
the α state, whereas the lower energy state (ground state) is defined as the 
β state. The difference in energy levels (  between the two states can be 
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1written as:
(1.2)
where ħ is a Planck’s constant, which is 6.663 × 10-34 J/s. Because , 
the frequency of the required electromagnetic radiation for the transition 
has the form:
(1.3)
The NMR signal intensity is owing to the population difference between the 
two Zeeman states at the transition. The Boltzmann distribution governs 
the populations of the energy states. The ratio of the populations in the 
states is quantitatively described by the Boltzmann equation:
(1.4)
where  and  denote the population of α and β states, respectively, T is 
the absolute temperature, and k is the Boltzmann constant (1.3805 x 10-23 
J/Kelvin)
1.2 Nuclei for MRS
Subatomic particles (protons and neutrons) of the nucleus contain 
an intrinsic property called spin. However, not all nuclei have nonzero 
spin. Nuclei that have both even atomic mass and even atomic number 
are NMR inactive (total spin = 0). All other nuclei that have an integer 
and half-integer nuclear spin quantum numbers (I) possess net spin. 
Table1.1 summarizes representative nuclei that show NMR phenomena, 
with their properties 
Table 1.1. erties of nPropuclear spins that show NMR phenomena
Type
Number of 
protons (Z)
Number of 
neutrons (N)
Nuclear spin 
number (I)
Example nuclei
1 Even Even 0 4He, 12C, 16O, 32S
2 Odd Even 1/2, 3/2, 5/2, etc. 1H (I = 1/2)
3 Even Odd 1/2, 3/2, 5/2, etc. 13C (I = 1/2), 15N (I = 1/2)
4 Odd Odd 1, 2, 3, etc. 2H (I =1), 14N (I = 1)
Most spectroscopy studies use the proton (1H) nucleus because of its high 
natural abundancy and its high sensitivity because of its high gyromagnetic 
ratio (Ƴ). In addition, proton spectroscopy is favorable because it can be 
performed with the same hardware used for MRI experiments. In addition 
to protons, other nuclei such as phosphorus (31P), sodium (23Na), and carbon 
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(13C) are also widely used when appropriate MR hardware is available, e.g., 
RF coils and amplifiers. Table 1.2 summarizes potential nuclei for NMR 
spectroscopy with their gyromagnetic ratio, spin, and natural abundancy 
(James 1975).
Table 1.2. Properties of widely used nuclei for biological NMR studies
Nucleus Symbol Gyromagnetic ratio (Ƴ) (MHz/T) Spin
Natural 
abundancy (%)
Sensitivity 
(vs. 1H) (%)
Proton 1H 42.577 1/2 99.98 100
Phosphorus 31P 17.235 1/2 100.00 6.63
Sodium 23Na 11.262 3/2 100.00 9.27
Carbon 13C 10.708 1/2 1.10 1.59
Nitrogen 15N -4.316 1/2 0.37 0.104
Oxygen 17O -5.772 5/2 0.04 3.70
Fluorine 19F 40.052 1/2 100.00 83.3
1.3 Chemical shift
Nuclei in different molecular environments resonate at slightly different 
frequencies because the electron cloud shields the nuclei from 
The change in the shielding factor can be caused by variations in the electron 
density. For example, when the observed nucleus is near a strongly 
electronegative group, the shielding factor decreases (less shielding, 
de-shielding or downfield); then, the chemical shift increases. This 
difference makes it possible to distinguish magnetically inequivalent 
nuclei in a molecule. However, isochronous (i.e., the same chemical 
shift) will not necessarily be magnetic equivalent because protons 
may form different types of bonds, homotopic, enantiotopic, and 
diastereotopic, which determine the appearance of the spectra. The 
chemical shift is a measure of how far the proton signal is from the 
reference signal. Therefore, this determines the position of the signal on 
the NMR spectrum. 
The chemical shift is expressed in ppm (parts per million), which is a 
field strength-independent unit. The ppm scale runs from the right 
(downfield) to the left (upfield).
          (1.5)
In-vivo proton spectroscopy measures the relative frequency of the 
proton nucleus of a metabolite compared with the proton resonance of 
tetramethylsilane (TMS) at 0 ppm.
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11.4 J-coupling
Magnetically non-equivalent nuclei interact via the bonding electrons. This 
indirect interaction is called spin-spin coupling or J-coupling (Ramsey and 
Purcell, 1952). J-coupling between the same species of spins is homonuclear 
J-coupling (e.g., proton-proton), and J-coupling between different spins
is heteronuclear J-coupling (e.g., proton-phosphorous). J-coupling is the
result of an internal indirect interaction of two spins via the intervening
electron structure of the molecule and modifies the spectral lineshape:
J-coupling splits a single peak into multiple peaks. In addition, J-coupling
modulates the signal intensity by TE, acquisition sequence, and parameters. 
Because the spin of a proton A has two possible orientations relative to an 
external field B0, the field BX at a neighboring proton X is either slightly 
increased or slightly decreased, leading to a splitting of the energy levels. 
The energies are shifted by
             (1.6)
where  is the projection of the spin of nucleus A onto the z-axis. The 
line separations in the splitting patterns are measured in Hz; they are 
characteristic of the efficiency of the spin interaction and are referred to 
as coupling constants (symbol: J). The coupling constant is independent of 
the external B0 field strength and has typical values of approximately 7 Hz 
for neighboring protons in proton spectroscopy.
A single-spin system (A) only has two energy levels: α and β, which are 
separated by Bohr’s frequency condition  Because only one 
possible energy level transition exists, the nucleus will have a 
single resonance at the frequency  (see Figure 1.3A). If we assume 
that there are two coupled nuclei, A and X, of the two-spin system, 
each of the single resonances at frequencies  and  will split into two 
equal peaks. However, the peak amplitudes are smaller than that of the 
singlet. This is referred to as a doublet (Figure 1.3B). The fundamental 
rule governing multiplet intensities for spin 1/2 nuclei with all identical 
couplings is Pascal’s triangle (n = number of equivalent couplings, see 
Table 1.3).
Chapter 1
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Figure 1.3. The energy level and corresponding NMR spectra for (A) uncoupled spin and (B) 
coupled two-spin systems. Uncoupled spin simply shows a singlet. Note that this diagram 
shows a simple doublet under the assumption that the chemical shift between A and X is 
greater than J. 
Table 1.3. Pascal’s triangle according to AX con igurations
n 2n Configuration Name Multiplet Intensities - Pascal’s triangle
0 1 A Singlet 1
1 2 AX Doublet 1  1
2 4 AX2 Triplet 1  2  1
3 8 AX3 Quartet 1  3  3  1
4 16 AX4 Pentet 1  4  6  4  1
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2.1 Acquisition methods
Single voxel spectroscopy (SVS) is widely used because of its robustness 
and the simplicity of its implementation and use. SVS acquires spectra that 
provide biochemical information and elucidation of molecular structure 
from a single target voxel that is relatively large (typically from 8 to 27 ml 
voxel). Therefore, this technique provides a spectrum with a high signal-
to-noise ratio (SNR) in a short scan time (less than 5 min). This technique is 
appropriate wherever the target region is homogeneous, and its size is not 
too small.
In contrast with the MR imaging sequence (Figure 2.1A), the single voxel 
spectroscopy sequence (Figure 2.1B) does not have phase encoding steps. 
Instead, a localization technique is used to specify a voxel of interest (VOI).
Figure 2.1. Sequence comparison between MRI (A) and MRS (B). 
Three sequential B0 field gradient pulses in three dimensions (x, y, and 
z) select three orthogonal slices to define a single VOI and only collect
the signal from the VOI (see Figure 2.2). Because the signal intensity is
proportional to the volume, a large spectroscopy volume is favorable to
obtain a signal with a good SNR. However, if the voxel is too large, there is
a risk of partial volume artifacts, which represents a situation that multiple
brain regions or tissue types are contained in the single VOI. To minimize the 
partial volume effect and maximize spectral SNR, careful voxel positioning
and voxel size optimization are required. The typical volume of the SVS is
8 ml.
Chapter 2
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Figure 2.2. Spatial localization technique achieved by three slice-selective RF pulses that 
intersect the voxel of interest (gray cube), where the spectroscopy signal is collected.
2.1.1  Standard acquisition 
Two fundamental acquisition techniques: PRESS (Point Resolved 
Spectroscopy) (Bottomley et al., 1988; Bottomley, 1984; Ordidge and 
Cresshull, 1986) and STEAM (Stimulated Echo Acquisition Mode) (Frahm 
et al., 1987; Granot, 1986; Kimmich and Hoepfel, 1987) have made this 
technique attractive in the spectroscopy community. Figure 2.3. shows 
the sequence diagrams of these two approaches. 
Figure 2.3. Comparison of two key acquisition sequences: PRESS (A) and STEAM (B). 
PRESS (Figure 2.3A) is a dominant acquisition approach used for proton 
spectroscopy. This sequence is composed of two spin-echoes, in which 
a slice-selective excitation pulse is combined with two slice-selective 
refocusing pulses. Therefore, this technique is also called the double 
spin-echo method. In PRESS, three radio frequency (RF) pulses, with flip 
angles of 90° - 180° - 180°, produce a spin echo signal from the selected 
voxel. Conversely, STEAM uses three 90° pulses (Figure 2.3B) to collect the 
stimulated echo signal from the VOI. The mixing time (TM) of STEAM is the 
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time delay between the second and third RF pulses. During the TM, spins 
rotate along the magnetic field, and there is no signal decay because of T2 
relaxation. Therefore, the TM is not included in TE. 
PRESS provides an SNR twice as high as STEAM if identical VOI is assumed 
and the same acquisition parameters, such as NEX, TE, and TR, are used 
because the STEAM signal is created from only half of the available 
equilibrium magnetization, whereas PRESS uses the full magnetization. 
However, STEAM shows the following advantages using only 90° pulses: 
In comparison with PRESS, STEAM allows the implementation with 
shorter TE, which leads to reducing the signal loss because of T2 
relaxation, as it uses a TM, and the 90° pulse can generally be shorter than 
the 180° pulse. In addition, because the 90° pulse usually has a sharper 
slice profile, requires less power than a 180° pulse, and shows less 
chemical shift displacement error (CSDE), STEAM is more favorable for 
ultrahigh fields (UHF) MRS (Tkáč et al., 2001). 
2.1.2  Editing acquisition 
Editing techniques (Mescher et al., 1998; Mescher et al., 1996; Rothman et 
al., 1993) are designed to discriminate J-coupled spins from noncoupled 
spins by exploiting the unique nuclear J-coupling properties of molecules. 
Spectral editing enables the observation of selective J-coupling 
interactions of a single coupled resonance. Using the fact that 
noncoupled and J-coupled spins show different responses to selective RF 
pulses, the difference between the selectively perturbed and 
nonperturbed spectra, which were individually acquired with and without 
the editing pulse, reveals the resonance of interest. Because metabolites 
that do not affect this particular perturbation show identical signals in 
perturbed and nonperturbed spectra; these resonances do not appear in 
the edited spectrum after subtraction. 
Most editing sequences (Mescher et al., 1998; Mescher et al., 1996; 
Rothman et al., 1993) utilize the fact that the phase of J-coupled spins is 
modulated in an echo sequence during the echo delay. A series of spectra, 
acquired with and without the editing pulse, may allow the separation 
and identification of overlapping signals from different molecules 
because of their different J-modulation. Figure 2.4 demonstrates the spin 
evolution by refocusing pulses for AX and AX2 spin systems. For fixed TE 
(TE = 1/J for AX, 1/2J for AX2), the peaks of coupled resonances are 
shifted by 180° in relation to those of uncoupled resonances. The second 
selective refocusing pulse will undo the coupled resonance phase shift 
without  affecting  the  entire spectrum. If  we  subtract  both  spectra, the  
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uncoupled resonances with the same phase in both cases will be 
removed. The coupled “edited” resonances add up, because they are 
usually in the anti-phase, which constitutes the basic principle of 
spectral editing. Spectral editing can be applied to any scalar coupled 
spin system. GABA (Mescher et al., 1998; Mescher et al., 1996), 
lactate(Sotak and Freeman, 1988), glutathione(Terpstra et al., 2003), 
and 2-hydroxyglutarate (2HG)(Choi et al., 2012b) are widely used 
metabolites as an in-vivo editing target.
Figure 2.4 Spin evolution by a refocusing pulse after the time 1/4J for the AX (A) and AX2 (B) 
systems. As the refocusing pulse simultaneously mirrors the coherences along the y-axis 
and inverts the spin-X populations, the echoes of the coherence will refocus with a phase 
shift of 180° between them. (Adapted from(Bogner et al., 2017)) 
2.1.3  GABA spectroscopy
γ-aminobutyric acid (GABA) is a major inhibitory neurotransmitter that is 
present at a concentration of approximately 1 mM in the human brain. 
GABA plays a vital role as a potential biomarker in neurological and 
neuropsychiatric disorders. GABA is composed of three methylene (CH2) 
groups, which form two triplet resonances at 3.01 and 2.28 ppm, and one 
quintet at 1.89 ppm (Figure 2.5). Because all three resonances are 
overlapped by adjunct metabolites with more intense concentrations, 
GABA is not discriminable in the standard spectroscopy spectrum without 
additional quantification steps, such as spectral fitting. Hence, the 
spectral editing approach is commonly used to detect GABA. 
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Figure 2.5 Chemical structure and simulated proton spectroscopy spectrum of γ-aminobutyric 
acid (GABA) at 7 T. GABA is composed of three methylene (CH2) groups and forms three 
resonance peaks at 3.01, 2.28, and 1.89 ppm. The color indicates each CH2 proton and its 
corresponding resonance. 
J-difference editing (Rothman et al., 1993) using MEGA-PRESS (Mescher
et al., 1998; Mescher et al., 1996) is a representative editing technique for
detecting GABA because this technique makes it possible to directly
measure the 3 ppm GABA peak. Figure 2.6A shows the sequence diagram
of the MEGA-PRESS sequence. MEGA-PRESS was primarily designed to
edit the GABA-4CH2 resonance at 3.01 ppm by selectively inverting the
magnetization of the GABA-3CH2 protons. Two additional slice-selective
pulses are located in the middle of time delays between the PRESS-
refocusing pulses. Figure 2.6 shows simulated example spectra of the
GABA resonance at 3 ppm for J-difference editing for MEGA-PRESS at 7 T
with TE =68 ms. In principle, this technique allows the detection of the
outer two peaks of the GABA triplet at 3.0 ppm because the central peak
of the triplet is canceled.
Figure 2.6 (A) Sequence diagram of MEGA-PRESS. Two additional frequency-selective RF pulses 
are combined with the conventional PRESS sequence. Simulated GABA-4CH2 spectra of MEGA-
ON, OFF, and DIFF. MEGA-ON: Spectrum with editing pulses at 1.89 ppm, MEGA-OFF: Spectrum 
without editing pulses, DIFF: Difference spectrum that isolates the GABA-4CH2 resonances by 
subtracting the MEGA-OFF spectrum from the MEGA-ON spectrum.
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2.1.4  Spectroscopy at ultrahigh field
As the static field strength increases, NMR spectroscopy yields several 
apparent benefits, improved SNR and increased spectral dispersion of 
the resonance frequencies owing to the chemical shift and simplification 
of J-coupling (Uğurbil et al., 2003). These result in an increased number 
of detectable metabolites with improved accuracy and precision. 
Therefore, the significance of magnetic resonance spectroscopy (MRS) 
continues to grow in UHFs. However, UHF MRS is accompanied by 
technical challenges such as B0 and B1 field inhomogeneities, CSDE, 
specific-absorption-rate (SAR) restrictions, susceptibility artifacts, 
shortened T2, and prolonged T1 relaxation times.
Improved acquisition sequences for 7 T MRS have been introduced 
to overcome these difficulties in comparison with the conventional 
acquisition methods such as STEAM and PRESS. Scheenen et al. (Scheenen 
et al., 2008a; Scheenen et al., 2008b) proposed a semi-localized by 
adiabatic selective refocusing (semi-LASER: sLASER) sequence that uses 
a nonadiabatic slice-selective excitation pulse and two pairs of adiabatic 
refocusing pulses. This sequence provides a shorter minimum TE, 
decreased CSDE, and lower SAR than those of the full LASER sequence, 
because only five RF pulses are used instead of seven. In addition to 
sLASER, MEGA-sLASER (Andreychenko et al., 2012), which is a 
combination of the conventional sLASER and two additional editing 
pulses, is also a conventional technique used to perform GABA editing at 
7 T. These two sequences were primarily used to acquire SVS data in this 
work. Detailed descriptions of these acquisition sequences are provided 
in Chapter 3.
2.1.5  Phased-array coil
Modern magnetic resonance (MR) systems are widely equipped with 
a multichannel receiver array to acquire MR data efficiently. A 
multichannel coil is an essential piece of MR hardware that makes it 
possible to improve the SNR and decrease the scan time in combination 
with parallel imaging techniques (Griswold et al., 2002; Pruessmann et 
al., 1999). Because MRS does not have phase encoding steps, it is not 
possible to accelerate the scan speed by a factor of the coil element 
number with the parallel imaging technique. However, because the SVS 
acquires signals from a relatively small voxel, all receiver coil elements 
acquire the same signal. Therefore, a receiver coil with increased coil 
elements can acquire a signal with quality similar to the signal acquired 
with a decreased coil number and an increased average time. Thus, an 
increased number of coil elements decreases the scan time.
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Figure 2.7 demonstrates the operating principle of the four-channel 
phased-array coil. Their corresponding weighting scores weight 
individually acquired spectra. 
Figure 2.7 Overview of multichannel array receiver. Individually acquired signals from each coil 
element are combined using the combination strategy. 
The combined signal M from N coil elements can be written as:
          (2.1)
where C is the weighting score of each coil element. m represents a signal 
from each coil elements Hitherto, the signal combination method (Roemer 
et al., 1990), which combines each coil data with the coil sensitivity in the 
time domain, has been widely used as a default combination method by 
scanner manufacturers because of its simplicity and speed. However, this 
method requires a weakly suppressed water signal to assess the sensitivity 
of each coil element. More importantly, this signal weighting scheme is 
not optimal for the low-concentration metabolites such as GABA. Detailed 
optimal coil weighting strategies are described in Chapter 4.
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2.2 Quantification methods
2.2.1  Brain metabolites
The fundamental goal of proton spectroscopy is to measure hydrogen-
containing metabolites in human and animal tissue noninvasively. It is 
widely known that approximately 20–25 metabolites are detectable by 
proton spectroscopy in the human brain; these have been found in previous 
in-vivo (Kreis, 1997) and ex-vivo (Perry et al., 1971a; Perry et al., 1971b) 
studies. Table 2.1 summarizes typical metabolites that are detectable using 
proton spectroscopy in the human brain.
Table 2.1 Typical metabolites which are detectable using proton spectroscopy in the human 
brain
Metabolite Formula
Chemical shift 
(ppm) (Govindaraju et al., 2000)
Concentration 
(mM/kg ww)
Alanine (Ala) C3H7NO2 3.775/1.467 0.3
Ascorbate (Asc) C6H8O6 4.449/4.002/3.743/3.716 1.4
Aspartate (Asp) C4H7NO4 3.891/2.801/2.653 2.1-3.1
Choline (Cho) C5H14NO 3.185/4.054/3.501 0–0.01
Phosphorylcholine (PCh) C5H15NO4P+ 3.027/3.913 0–0.95
Glycerophosphorylcholine (GPC) C8H20NO6P 3.650/3.672/3.903/3.871/3.946 0.5
Creatine (Cr) C4H9N3O2 3.0270/3.9130 3.2–5.8
Phosphocreatine (PCr) C4H10N3O5P 3.0290 2.2–4.5
γ-Aminobutyric acid (GABA) C4H9NO2 3.9300 1.3–2.5
Glutamine (Gln) C5H10N2O3 3.7530/2.2190/2.1090/2.4320/2.4540 1.6–2.2
Glutamate (Glu) C5H9NO4 3.7433/2.0375/2.2100/2.3378/2.3520 8.9–12.8
Glutathione (GSH) C10H17N3O6S 3.3769/4.5608/2.2964/2.9747/3.7690… 1.1–1.4
Glycine (Gly) C2H5NO2 3.5480 1.2
Glucose (Glc) C6H12O6 5.216/3.519/3.698/3.395/3.822/3.826… 1.4–2.2
Myo-Inositol (MI) C6H12O6 3.5217/4.0538/3.5217/3.6144/3/2690… 4.9–5.7
Scyllo-Inositol (Scyllo) C6H12O6 3.3400 0.3–0.4
Lactate (Lac) C3H6O3 4.0974/1.3242 0.5–0.7
N-Acetylaspartate (NAA) C6H9NO5 2.2208/4.3817/2.6727/2.4863/7.8205 11.0–13.5
N-Acetylaspartylglutamate (NAAG) C11H16N2O8 4.12/2.06/1.90/2.20/2.21/7.95/4.63… 1.0–1.1
Phosphorylethanolamine (PE) C2H8NO4P 3.9765/3.2160 1.6–2.8
Taurine (Tau) C2H7NO3S 3.4206/3.2459 1.3–3.3
2.2.2  Spectral quantification
Observed in-vivo spectroscopy signals are considered to be a linear 
summation of each metabolite signal. Therefore, the acquired in-vivo 
signal S can be simply described as:
          (2.2)
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where C is the concentration of the metabolite, M represents the 
metabolite signal, and e is a noise or error term. Because potential 
metabolites in the VOI are already known, spectral quantification is a 
procedure to estimate the concentration of each metabolite based on the 
spectral model M. The spectral model of each metabolite can be acquired 
by scanning the metabolite separately in a phantom (Govindaraju et al., 
2000), or simulated by quantum mechanical calculations (Smith et al., 
1994) based on the measured chemical shift and J-coupling from high-
resolution spectra acquired at physiological values of temperature and 
pH. The simulation method is used because of its convenience and 
simplicity. 
Metabolite concentrations can be estimated by spectral fitting in the time 
or frequency domain. Table 2.2 summarizes various established fitting 
methods and their main features. Because a Fourier transform is a linear 
operation, the two domains are equivalent. Therefore, the quantification 
results should be similar regardless of the domain or quantification 
approach. However, the acquired spectrum does not always show an ideal 
form because of unwanted external factors such as B0 field 
inhomogeneity, eddy currents, the patient’s motion, and insufficient 
water suppression. Therefore, the optimal selection of the analysis 
domain and method plays a vital role in a successful quantification 
outcome since each method deals with these problems by the different 
optimization algorithms of the acquisition and spectral preprocessing.
Table 2.2. Comparison of spectral fitting algorithms and their features.
Name Domain Fitting algorithm Optimization Baseline 
correction
Reference
LCModel FD Linear least square fitting VARPRO Yes (Provencher, 1993)
AMARES TD Nonlinear least square fitting
Nonlinear least 
square solver
No (Vanhamme et al., 1997)
QUEST TD
Linear least square 
fitting
Levenberg-
Marquardt Yes (Van der Veen et al., 1988)
AQSES TD
Linear least square 
fitting VARPRO Yes (Poullet et al., 2007)
MIDAS TD Nonlinear least square fitting
Levenberg-
Marquardt Yes (Maudsley et al., 2006)
PROFIT TD/FD
Linear least square 
fitting VARPRO Yes (Schulte and Boesiger, 2006)
2.2.3  LCModel
We mainly used LCModel (Linear Combination Model) (Provencher, 
1993, 2001) as the quantification tool in this study, for which this 
subsection provides a detailed description. LCModel is a commercial 
software package that analyzes MRS data in the frequency domain 
and is currently the most widely used software package in 
spectroscopy because it supports  formats from all scanner manufacturers
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such as Siemens, GE, Philips, and Bruker. In addition, LCModel has 
an almost automated software: phase, frequency, and baseline corrections 
are included by default. LCModel quantifies the observed in-vivo 
spectrum as a linear combination of in-vitro spectral models acquired 
from metabolite solutions or simulation under an identical in-vivo scan 
environment. This prior knowledge is called the “basis-set.” 
LCModel performs the least square fitting in the frequency domain. 
The measured in-vivo spectrum is compared with a linear 
combination of individual spectra from this basic set. The coefficient for 
each basis function is estimated to obtain the best fit to the in vivo 
spectrum. These linear combination coefficients give the maximum-
likelihood estimate of the concentration of each metabolite. LCModel 
performs optimization steps for the lineshape and linewidth distortion 
by the B0 field inhomogeneity, the frequency shifts by the magnetic 
susceptibility difference, phase, and baseline, along with the linear 
spectral coefficients. The goodness of fit is also estimated according to 
the Cramér–Rao lower bound (CRLB), which represents the lower limit 
of the statistical errors of the fitted parameters, which are determined 
by the SNR of the spectrum and the mutual interdependence of 
the model parameters (Kreis, 1997). 
LCModel quantifies the absolute concentration of each metabolite in 
mM/kg wet weight using water scaling (Provencher, 1993, 2001,2016). 
The calculated absolute quantification of the metabolites Cm is  
          (2.3)
where Am and Aw are the areas under the fitted metabolite line and water 
line acquired additionally without water suppression, respectively. Attm 
and Attw are corrections for the T1 and T2 relaxation times for water and 
metabolite, respectively. Cw is the known water concentration (assumed 
water content of 43300 mM for gray matter and 35880 mM for white 
matter) (Ernst et al., 1993; Kreis et al., 1993).
2.2.4  Correction factors
1. Tissue volume fraction
Each metabolite has unequal concentrations in gray matter (GM) and white 
matter (WM). Table 2.3 summarizes the literature values of metabolic 
distribution in GM and WM for normal human brain metabolites that 
are detectable using proton spectroscopy. Because the voxel size of 
SVS is relatively large, the tissue volume fraction of the VOI needs to be 
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considered. Because T1 weighted images are routinely acquired to position 
the spectroscopy voxel, we can separate the GM, WM, and CSF volume by 
the image segmentation technique (Ashburner and Friston, 2005). The 
following equation compensates tissue volume-induced concentration 
variations,
          (2.4)
where S(M) is the signal intensity of the metabolite, f is a volumetric 
fraction, and D is the metabolic distribution of the tissue.
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Table 2.3 Metabolite concentration and fractional contribution in GM and WM measured by 
previous in-vivo and ex-vivo studies. 
In-vivo proton spectroscopy Ex-vivo amino acid analyzer (Perry et al., 1971a)
Metabolite
Concentration
(mmol/kg, wet weight*
mmol/kg, water**
a.u.***)
Fraction value 
(%) Brain Region Technique Reference
Concentration
(mmol/kg, wet weight) Fraction value (%)
GM WM GM WM GM WM GM WM
Ala 1.3±0.22 1.1±0.20 54.17 45.83
Asp 3.8±0.6* 2.9±0.6 56.72 43.28 Cingulate & Corona Radiata SVS
(Bank et al., 
2015)
2.56±0.81 1.16±0.38 68.82 31.18
Cho
1.35±1.5* 1.58±1.1 46.08 53.92 Multiple Multiple (Kreis, 1997)
679±12*** 858±15 44.18 55.82 Frontal MRSI (Maudsley et 
al., 2009)
1.2±0.2* 1.4±0.2 46.15 53.85 Total MRSI (Tal et al., 2012)
PCh 0.2±0.2* 0.0±0.1 100 0 Centrumsemiovale & Occipital SVS
(Hofmann et 
al., 2002)
GPC 1.3±0.3* 1.9±0.3 40.62 59.38 Centrumsemiovale & Occipital SVS
(Hofmann et 
al., 2002)
PCh +GPC 1.3±0.1* 1.9±0.3* 40.62 59.38 Cingulate & Corona Radiata SVS
(Bank et al., 
2015)
Cr
8.36±0.7* 6.27±1.0 57.14 42.86 Multiple Multiple (Kreis, 1997)
3145±42*** 2936±59 51.72 48.28 Frontal MRSI (Maudsley et 
al., 2009)
6.7±0.6* 4.8±0.4 58.26 41.74 Total MRSI (Tal et al., 2012)
17.40±1.51** 9.05±0.93 65.81 34.09 Multiple MRSI (Gasparovic et 
al., 2009)
GABA
2.87±0.61** 0.33±0.1 89.69 10.31 Sensorimotor SVS (Bhattacharyya 
et al., 2011)
2.32±0.34 0.26±0.12 89.92 10.08
1.1±0.1** 0.4±0.1 73.33 26.67 Prefrontal SVS (Choi et al., 
2006)
1.3±0.36** 0.16±0.16 89.04 10.96 Posterior MRSI (Choi et al., 
2007)
1.00* 0.15 86.96 13.04 Occipital SVS (Ganji et al., 
2014)
1.91±2.65*** 1.29±2.11 59.69 40.31 Cingulate SVS (Geramita et al., 
2011)
0.96±0.24** 0.44±0.16 68.57 31.43 Posterior MRSI
(Jensen and 
Renshaw, 
2005)
4.67*** 3.16 59.64 40.36 Posterior MRSI (Zhu et al., 
2011)
Glc 1.1±0.66** 1.7±0.88 39.29 60.71 Visual SVS (De Graaf et al., 2001)
Gln 3.02±0.46* 1.9±0.54 61.38 38.62 Anterior Cingulate SVS (Zhang and Shen, 2015) 3.75±0.25 2.56±0.38 59.43 40.57
Glu
21.44** 8.39 71.87 28.13 Total MRSI (Gasparovic et 
al., 2009) 8.64±0.83 5.54±1.01 60.93 39.07
11.11±0.89** 8.21±0.95 57.51 42.49 Anterior Cingulate SVS (Zhang and 
Shen, 2015)
Gly 1.1±0.1* 0.1±0.1 91.67 8.33 Frontal Cortex SVS (Banerjee et al., 2012) 1.80±0.55 1.44±0.39 55.56 44.44
MI
5.92±1.6* 4.85±2.1 54.97 45.03 Multiple Multiple (Kreis, 1997)
5.4±0.7* 4.6±0.7 54.00 46.00 Total MRSI (Tal et al., 2012)
GSH 3.3±0.1 2.1±0.4 61.11 38.89 Multiple MRSI (Srinivasan et al., 2010)
Lac 0.8±0.3* 0.9±0.3 47.06 52.94 Cingulate & Corona Radiata SVS
(Bank et al., 
2015)
NAA
10.32±0.9* 9.86 + 0.7 51.14 48.86 Multiple Multiple (Kreis, 1997)
8.4±0.9** 8.0±0.9 51.22 48.78 Multiple SVS (Pouwels and 
Frahm, 1998)
4523±59*** 4857±67 48.22 51.78 Frontal MRSI (Maudsley et 
al., 2009)
8.4±0.7* 7.6±0.5 52.50 47.50 Multiple MRSI (Tal et al., 2012)
20.96±0.84** 17.22±1.61 54.86 45.14 Multiple MRSI (Gasparovic et 
al., 2009)
NAAG 0.9±0.5** 2.3±0.4 28.13 81.87 Multiple SVS (Pouwels and Frahm, 1998)
PCr 8.1±0.5* 7.8±0.5 50.94 49.06 Cingulate & Corona Radiata SVS
(Bank et al., 
2015)
PE 1.03±0.25 0.45±0.10 80.47 19.53
Scyllo 0.3±0.1* 0.3±0.1 50.00 50.00 Cingulate & Corona Radiata SVS
(Bank et al., 
2015)
Ser 0.81±0.19 0.67±0.20 54.73 45.27
Tau 1.24±0.45 1.33±0.35 48.25 51.75
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2. T2 relaxation time
Two spectra acquired at different TEs show necessarily different signal 
intensities because of the T2 relaxation effect. The signal intensity 
differences were also compensated (Edden et al., 2012a) for T2. The TE 
dependence of the GABA signal relative to the signal at TE = 0 ms for the 
sLASER approach can be described as:
(2.5)
For the GABA editing approach, we need an additional sine term because 
of coupling evolution, as we are measuring the side-lobes of the triplet that 
has a J-modulated intensity variation with TE. Then, the TE dependency of 
the edited GABA signal is
(2.6)
Table 2.4 summarizes T1 and T2 relaxation times in the GM and WM for 
representative brain metabolites at 7 T.
Table 2.4 T1 and T2 relaxation times for representative metabolites at 7 T
Metabolite T1 (s) T2 (ms) Reference
Cho 1.24 ± 0.21 131 ± 16
(Li et al., 2012)Cr 1.78 ± 0.23 121 ± 12
NAA 1.73 ± 0.22 170 ± 11
GABA 1.33 ± 0.58 63 ± 19 (Andreychenko et al., 2013; Intrapiromkul et al., 2013)
2.3 Thesis outline
Chapter 3 compares two representative GABA measurement methods, 
GABA-editing and non-editing acquisition in combination with the LCModel 
quantification. This study determines which approach is optimal for 
estimating GABA in terms of spectral fitting quality at 7 T. Simultaneous 
interleaved acquisition with our modified sequence minimizes the 
differential effect of extraneous factors and enables an accurate 
comparison of two measurements. 
In Chapters 4 and 5, we discuss two approaches for improving spectral 
quantification. A multichannel phased-array coil is a widely used piece of 
hardware for magnetic resonance imaging (MRI) and MRS, which improves 
the SNR and reduces the scan time. Chapter 4 modifies existing combination 
methods to maximize the advantage of multichannel acquisition in terms 
of GABA quantification and the spectral fitting quality. Chapter 5 proposes 
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a new quantification approach to overcome B0 field inhomogeneity. A 
good B0 field homogeneity is an essential requirement for accomplishing 
the fundamental objective, which is estimating metabolite concentrations 
within the voxel. Because shimming is challenging at UHFs, the results of 
the tests of water lineshape fitting models, which are mostly independent 
of B0 field homogeneity, are presented in this chapter. 
Chapter 6 investigates one problem that has largely been ignored by the 
spectroscopy community, i.e., a potential frequency shift caused by the 
magnetic susceptibility differences between gray and white matter. We also 
demonstrate its utilization to quantify the relative metabolic distribution 
in gray and white matter.
Chapter 7 summarizes and discusses this work.


CHAPTER 3.
A comparison of sLASER and MEGA-sLASER 
using simultaneous interleaved acquisition for 
measuring GABA in the human brain at 7T
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Abstract
γ-Aminobutyric acid (GABA), the major inhibitory neurotransmitter, is challenging to 
measure using proton spectroscopy due to its relatively low concentration, J-coupling 
and overlapping signals from other metabolites. Currently the prevalent 
methods for detecting GABA at ultrahigh field strengths (>= 7 T) are GABA-
editing and model fitting of non-editing single voxel spectra. These two 
acquisition approaches have their own advantages: the GABA editing 
approach directly measures the GABA resonance at 3 ppm, whereas the 
fitting approach on the non-editing spectrum allows the detection of multiple 
metabolites, and has an SNR advantage over longer echo time (TE) 
acquisitions. This study aims to compare these approaches for estimating 
GABA at 7 T. We use an interleaved sequence of semi-LASER (sLASER: TE = 38 
ms) and MEGA-sLASER (TE = 80 ms). This simultaneous interleaved acquisition 
minimizes the differential effect of extraneous factors, and enables an accurate 
comparison of the two acquisition methods. Spectra were acquired with an 8 
ml isotropic voxel at six different brain regions: anterior-cingulate cortex, 
dorsolateral-prefrontal cortex, motor cortex, occipital cortex, posterior 
cingulate cortex, and precuneus. Spectral fitting with LCModel quantified the 
GABA to total Cr (tCr: creatine + phosphocreatine) concentration ratio. After 
correcting T2 relaxation time  variations, GABA/tCr ratios were similar between 
the two acquisition approaches. GABA editing showed smaller spectral fitting 
errors according to Cramér–Rao lower bound than the sLASER approach for all 
regions examined. We conclude that both acquisition methods show similar 
accuracy but the precision of the MEGA-editing approach is higher for GABA 
measurement. In addition, the 2.28 ppm GABA resonance was found to 
be important for estimating GABA concentration without macromolecule 
contamination in the GABA-edited acquisition, when utilizing spectral fitting 
with LCModel.
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3.1 Introduction
γ-Aminobutyric acid (GABA), the major inhibitory neurotransmitter, 
is present at about one millimolar concentration in the human brain 
(McCormick, 1989). GABA plays an important role as a potential biomarker 
in neurological and neuropsychiatric disorders such as cancer (Bellance et 
al., 2012), multiple sclerosis (Cawley et al., 2015), Alzheimer’s disease (Bai 
et al., 2015), epilepsy (Petroff et al., 1995), schizophrenia (Marsman et al., 
2014), and autism (Oblak et al., 2011).
Existing in-vivo approaches for measuring GABA include positron emission 
tomography (PET) (Lingford-Hughes et al., 2002), single photon emission 
tomography (SPECT) (Verhoeff et al., 1999), proton magnetic resonance 
spectroscopy (1H MRS) (Keltner et al., 1996) and chemical exchange 
saturation transfer (CEST) (Cai et al., 2012; Yan et al., 2016). Among these, 
MRS at ultrahigh filed (UHF >= 7 T) is widely used due to high sensitivity 
and specificity for measuring GABA (Godlewska et al., 2017a). 
Nevertheless, GABA MRS is still challenging by reason of its low 
concentration and resonances overlapping with higher concentration 
signals (Puts and Edden, 2012). Previously, various acquisition strategies 
for proton MRS have been proposed for measuring GABA, such as J-editing 
(Rothman et al., 1993) (e.g. MEGA-PRESS (MEsher-GArwood Point RESolved 
Spectroscopy) (Mescher et al., 1998; Mescher et al., 1996)) and double 
quantum filters (Shen et al., 2002). 
The MEGA-editing method (Puts and Edden, 2012) is the most commonly 
used approach. A MEGA pulse is used to distinguish the GABA signal at 
3 ppm from the overlapping creatine signal, based on the J difference 
editing approach (Mescher et al., 1998; Mescher et al., 1996). MEGA-editing 
combines conventional localization techniques with one or more additional 
frequency selective editing pulses, which invert the signal at 1.9 ppm. As the 
GABA resonance at 3 ppm signal is coupled to the 1.9 ppm GABA resonance, 
the difference between the signals obtained with and without the editing 
pulses should give an unambiguous GABA signal at 3 ppm. However, the 
MEGA-editing method also has disadvantages. It theoretically works best 
at certain echo times (TEs), when the GABA is refocused in anti-phase to the 
signal obtained without editing pulses (TE = (2n-1) / 2J, where J is 7.35 Hz, n 
= 1, 2, 3…). Therefore, the TE for GABA editing is largely standardized at 
68 ms as the next possible TE beyond 68 ms (204 ms) would imply a?
??????????? T2 decay of the signal. At 7 T, it is quite challenging to implement 
the MEGA-semi-LASER(MEGA-sLASER) sequence with TE = 68 ms due to 
the lack of time to insert all pulses within 68ms. Therefore, longer TEs 
have frequently been used (e.g., 72 ms (Chen et al., 2017) and 74 ms 
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Houtepen et al., 2017; Marsman et al., 2014). However, Edden, et al. 
(Edden et al., 2012b) reported that a TE of 80 ms showed a reduction in co-
edited macromolecule (MM) compared to TE 68 ms even though the GABA 
SNR is reduced by approximately 7 % in comparison with that of TE = 68 ms 
due to the combined but opposing effects of increased editing efficiency 
and greater T2-relaxation. In addition, motion, respiration, and frequency 
drift induce experimental instabilities that may result in subtraction 
artifacts (Harris et al., 2014). 
Another extensively used GABA measurement method is to obtain a non-
edited spectrum, and measure the GABA signals using spectral fitting via 
LCModel (Provencher, 1993, 2001). As these data are normally acquired at 
a shorter TE, the acquired spectrum is superior to the edited spectrum in 
terms of sensitivity. In addition, not only GABA but also all metabolites are 
quantified simultaneously. However, a spectral fitting procedure is required 
in order to measure metabolite concentrations. Previously, a number of 
studies have shown the feasibility of GABA detection in combination with 
LCModel analysis at different field strength: 3 T (Napolitano et al., 2013; 
Near et al., 2013), 4 T (Öz et al., 2006) and 7 T (Ganji et al., 2014; Wijtenburg 
et al., 2013). Even though GABA is detectable at various field strengths, 
it has also been reported that spectra that are acquired at higher field 
strength show superior fitting precision due to the high spectral dispersion, 
better SNR and simplified spectra (Pradhan et al., 2015).
Given these two leading but different GABA measurement techniques: 
GABA-editing and non-editing acquisitions, there have been various 
attempts to assess their relative merits. Terpstra, et al (Terpstra et al., 
2005) compared STEAM (Stimulated Echo Acquisition Mode (Frahm et al., 
1987; Granot, 1986; Kimmich and Hoepfel, 1987), TE = 5 ms) with MEGA-
PRESS (TE = 68 ms) at 4 T in a validation study measuring glutathione (GSH). 
The concentrations of GSH measured with these two methods in that study 
were similar, suggesting a similar sensitivity of the two techniques for those 
conditions. Sanaie Nezhad, et al (Sanaei Nezhad et al., 2017) compared the 
accuracy and sensitivity of PRESS (Point RESolved Spectroscopy (Bottomley 
et al., 1988; Ordidge et al., 1986), TE = 35 ms) and MEGA-PRESS (TE = 130 
ms) at 3 T to measure GSH, and found that PRESS is not an accurate and 
reliable method to measure GSH in vivo. They also showed that the spectral 
fitting of the PRESS spectra cannot reliably quantify the concentration of 
GSH when the concentration is 4 mM or less. In addition, one conference 
proceeding by Chen, et al (Chen et al., 2015) reported that the GABA to total 
Cr (tCr: creatine (Cr) + phosphocreatine(PCr)) ratios from occipital cortex 
(OC) and motor cortex (MC), measured by the MEGA-sLASER (TE = 72ms) 
and STEAM (TE = 17ms) approaches, are comparable after T2 relaxation 
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correction. However, after MM correction, GABA editing results were 
superior to those of the non-editing spectral acquisitions in terms of both 
reliability and reproducibility. Nevertheless, the authors still suspected 
that MM contamination and editing efficiency might have had an influence 
on GABA quantification.
In addition, it is widely known that the 3 ppm signal measured with the 
GABA-editing technique is typically contaminated by co-edited MM due to 
the overlapped resonance frequencies of the GABA and MM by the editing 
pulse, and this is generally considered to be a methodological limitation of 
this approach (Behar and Ogino, 1993; Behar et al., 1994; Puts and Edden, 
2012). Therefore, this measured 3 ppm signal is commonly referred 
to as GABA+: GABA ‘plus’ co-edited MM (Mescher et al., 1998). 
A standard approach to obtain (relative) GABA concentrations 
from non-edited single voxel spectroscopy (SVS) spectra is to use 
LCModel (Provencher, 1993, 2001) that fits metabolites together with 
additional MM, and lipid baselines. Furthermore, the GABA signal is 
fitted to all three methylene groups of GABA, of which the resonance 
at 2.28 ppm is uncontaminated by the MM signal. This should ensure that 
the GABA estimated in this way does not include MM. We hypothesize 
that if the MEGA-edited spectrum also contains a visible signal at 2.28 
ppm then the application of LCModel will similarly yield estimates of 
GABA concentration that are free of MM contamination. We can test 
this hypothesis by obtaining spectra from the same voxel using both 
acquisition techniques, to test whether the GABA concentrations 
obtained are the same. This study aims to compare two GABA 
measurement methods in combination with LCModel fitting by 
comparing relative GABA concentrations and corresponding spectral 
fitting quality at various brain regions of healthy individuals. In order to 
minimize the effect of external factors, a single interleaved sequence, 
which acquires spectra of the two measurement methods 
simultaneously was used. As a result, factors such as motion, shim, and B1 
inhomogeneity should be the same for both techniques.
3.2 Materials and Methods
3.2.1  Sequence implementation
The MEGA method can be implemented with conventional SVS 
acquisition methods. It was initially implemented in a PRESS sequence 
(Bottomley et al., 1988; Mescher et al., 1998; Mescher et al., 1996; 
Ordidge et al., 1986). However, at the ultrahigh field, PRESS loses 
efficiency because of  B1  filed  inhomogeneity. In  contrast,  the  sLASER
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sequence (Scheenen et al., 2008a) offers improved performance mainly 
because of the use of adiabatic refocusing pulses that are insensitive 
to B1 field inhomogeneity and have high bandwidth, leading to a small 
chemical shift displacement error (CSDE) (Scheenen et al., 2008b). 
In this study, the sLASER sequence was used to acquire non-editing in-vivo 
spectra, and MEGA-editing was performed on the basis of the same sLASER 
sequence, termed MEGA-sLASER (Andreychenko et al., 2012). 
MEGA-sLASER and sLASER SVS spectra were acquired using a single 
interleaved sequence shown in Figure 3.1. It consists of the repeated 
application of four sub sequence blocks: a MEGA-off sLASER, a MEGA-on 
sLASER, and two sLASER acquisitions. The repetition time (TR) of each 
sub sequence block was 4500 ms.
Figure 3.1. The pulse sequence diagram of the interleaved MEGA-semi-LASER (TE = 80 ms) 
and semi-LASER (TE = 38ms) sequence implemented in the current study. This sequence is 
composed of four sub-sequence blocks, which have identical TRs of 4500 ms.
In the implementation of the sLASER sequence with TE = 38 ms, a Shinnar-
Le Roux (SLR) 90º excitation pulse (duration = 3.4 ms and bandwidth = 3.5 
kHz) was used for slice selection in one direction and two pairs of hyperbolic 
secant 180º refocusing pulses (duration =5 ms and bandwidth = 5.3 kHz) 
were used for slice selection in the two other directions. The spoiler 
gradients had an amplitude of 25 mT/m and their duration varied between 
0.8 and 2 ms. WET (Water suppression Enhanced through T1 effects) water 
suppression (Ogg et al., 1994) with four RF pulses was used to suppress 
the water signal. This has a lower sensitivity to B1 variations compared 
with the three RF pulses WET water suppression. The water suppression 
block was placed before the localization block of the sequence and is not 
depicted in the sequence diagram. TE of 38 ms for this sequence is a 
slightly conservative choice  to ensure elimination of unwanted signal 
and but comparable to those of other  sLASER studies at  the  same field 
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strength; 24 ms (Terpstra et al., 2016), 25 ms (Boer et al., 2011), 28 ms 
(Marsman et al., 2014), 32 ms (Pradhan et al., 2015) and 36ms (Ip et al., 
2017). 
MEGA-sLASER was implemented with a TE of 80 ms (Edden et al., 
2012b). Increased number of gradient pulses were required to have 
sufficient gradient performance, TE is slightly longer than the ideal value. 
Localization components of this sequence were the same as for the sLASER, 
as described above. A pair of dual-band inversion pulses (duration = 
11.52 ms and bandwidth = 133 Hz) was used for both the MEGA-editing 
and extra water suppression. This editing pulse inverts at 1.9 and 4.7 ppm 
in on-mode, and at 4.7 and 7.5 ppm in off-mode. Since additional MM 
suppression was not included in the acquisition sequence except a 
prolonged TE of 80 ms, our measured GABA signal at 3 ppm is also GABA 
plus.
3.2.2  Ethics statement
The study was conducted at the Erwin L. Hahn Institute for Magnetic 
Resonance Imaging, University of Duisburg-Essen, Essen, Germany. 
The experimental protocol was approved by the Ethics Commission 
of the Medical Faculty of the University Duisburg-Essen (study number 
11–4898-BO). All participants provided written informed consent in 
accordance with the declaration of Helsinki
3.2.3  Data acquisition
12 healthy volunteers (9 male and 3 female subjects, 29.33 ± 4.49 years 
old) participated in this study. Experiments were performed on a 7 T 
whole body system (Magnetom, Siemens, Erlangen, Germany) with a 1 Tx-
birdcage/32 Rx-loops array (Nova Medical, Wilmington, MA). First, T1 
weighted images were acquired as an anatomical reference using a three-
dimensional magnetization-prepared rapid gradient-echo (3D MPRAGE) 
(Mugler and Brookeman, 1990) with the following scan parameters: 256 
slices, slice thickness = 1 mm, TR = 2500 ms, TE = 1.35 ms, inversion time 
(TI) = 1100 ms, flip angle = 6°, field of view = 256 x 256 x 256 mm3, scan 
time  ≈ 5 min. B0 shimming was performed using FASTESTMAP (Gruetter 
and Tkáč, 2000). Single voxel MRS data were collected from 20 x 20 x 20 
mm3 voxels positioned at anterior cingulate cortex (AC), dorsolateral 
prefrontal cortex (DLPFC), MC, OC, posterior cingulate cortex (PC), and 
precuneus (PRC) using the interleaved MEGA-sLASER and sLASER 
sequence (TR = 4500 ms, TEs = 80, 80, 38 and 38 ms, 32 averages of each 
sub-sequence, bandwidth = 3000 Hz, data points = 1024 and total scan 
time ≈ 10 min).
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3.2.4  Data processing
The signals from each coil element were combined by the signal 
weighting method (Roemer et al., 1990) that the manufacturer provides 
by default. MEGA difference spectra were calculated with the jMRUI 
software package (Version 6.0, http://www.jmrui.eu) (Naressi et al., 
2001a; Naressi et al., 2001b). The nominal spectral resolution was 
increased to 0.27 Hz by zero filling for a more exact adjustment. The 
MEGA-edited spectra were acquired by subtracting MEGA-on and MEGA-
off spectra after alignment with the 3ppm peak by the horizontal shift 
along the frequency axis, to avoid subtraction artifacts (Harris et al., 2014) 
caused by frequency drift. After subtraction, 1 Hz line broadening was 
applied to remove the zero-filling induced high-frequency noise. The 
same levels of zero-filling and line broadening were applied to the GABA-
editing and the non-editing acquisition spectra.
3.2.5  Data analysis
Spectral quality was evaluated on the basis of the SNR and the linewidth 
was measured using the 2 ppm resonance of total N-acetylaspartate 
(NAA) and the standard deviation of the white noise area in the 7 to 9 ppm 
range, for both GABA-editing and non-editing acquisition spectra.
LCModel software (Version 6.3-1L, Stephen Provencher, Ontario, Canada) 
(Provencher, 1993, 2001) was used to estimate metabolite 
concentrations. The Cramér–Rao lower bound (CRLB), was taken as giving 
the error in the metabolite quantification (expressed in %SD) 
(Provencher, 1993). For the basis set for the LCModel analysis, parametric 
spectral models of alanine (Ala), aspartate (Asp), ascorbate (Asc), 
glycerophosphocholine (GPC), choline (Cho), phosphocholine (PCh), Cr, 
PCr, GABA, glucose (Glc), glutamine (Gln), glutamate (Glu), glycine (Gly), 
GSH, myo-inositol (mI), lactate (Lac), NAA, N-acetylaspartylglutamate 
(NAAG), phosphoethanolamine (PE), scyllo-inositol (Scyllo) and taurine 
(Tau) were simulated using the NMRSIM module included in TOPSPIN 
suite (Version 3.6, Bruker, Rheinstetten, Germany) with identical 
parameters (e.g. RF pulse profile, RF pulse timing, resonance frequency, 
and acquisition bandwidth) to those used for the in-vivo acquisition. 
Chemical shift and J-coupling values for each metabolite were taken from 
(Govind et al., 2015; Govindaraju et al., 2000).
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For the sLASER data, the basis set for the LCModel analysis 
consisted of all twenty-one simulated metabolites. For the GABA 
editing method, six edited metabolites were modelled: GABA, Glu, 
Gln, NAA, NAAG, and GSH were included in the basis set. Each 
edited spectral model was created by subtracting a simulated MEGA-
off spectrum from a simulated MEGA-on spectrum. As LCModel 
performs a phase correction during spectral fitting, additional phase 
correction steps were not applied
For MM and lipid signals, the non-parametric basis sets that LCModel 
provides by default were used (Provencher, 2016). However, one singlet 
peak with Lorentzian lineshape was also included in the GABA-editing 
basis set model the MM signal at 3 ppm, and thus avoid over-
estimation of GABA due to the co-edited MM (Bhagwagar et al., 2007).
We report regional GABA concentrations as a ratio relative to tCr that 
was normalized across the scans. We used the tCr signal in the MEGA-off 
spectrum as an internal reference for the MEGA-editing approach. 
Previous studies used cut-off criteria of 20 % (Raschke et al., 2012) or 
30% (Chowdhury et al., 2015) for CRLB, our study included all GABA and 
Cr results to avoid CRLB thresholding leading to a bias in measuring low 
concentration metabolites (Kreis, 2016). Spectral fitting quality was 
compared with CRLB. In addition, absolute uncertainty was calculated by 
multiplying the relative CRLB by the estimated concentration (Kreis, 
2016).
As the data were acquired at different TEs, the signal concentration 
differences were also compensated (Edden et al., 2012a) for T2. We 
assumed similar T2 relaxation times in GM and WM for each 
metabolite, and used values taken from the literature of: T2 tCr = 121 ms 
and T2 GABA = 63 ms (Intrapiromkul et al., 2013) at 7 T. T1 weighted images 
of each spectroscopy voxel of interest (VOI), which were also used for 
spectroscopy voxel placement, were segmented using SPM12 (Wellcome 
Trust Centre for Neuroimaging, University College London, UK) unified 
segmentation routines to determine the relative proportions of GM, WM 
and cerebrospinal fluid (CSF) within the spectroscopy voxel. We 
calculated a volume fraction for each tissue component. 
Regional GABA concentrations and CRLBs were also compared with a one-
way ANOVA was performed using SPSS (Ver. 22, IBM, NY). The null 
hypothesis was that there is no difference between regions. A p-value 
less than 0.05 was considered statistically significant. Bland-Altman 
analysis (Bland  and Altman,  1986)  as  implemented in MedCalc Statistical 
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3.3 Results
Water linewidths obtained after performing 2 - 3 iterations with the 
FASTESTMAP sequence were below 14 Hz for all voxels. Figure 3.2A 
depicts locations of VOIs on the GM (gray) and WM (white) maps after the 
T1 weighted image segmentation. Figure 3.2B shows examples of fitting 
GABA with LCModel using sLASER (top) and the MEGA-sLASER (bottom) 
for all six regions. Table 3.1 summarizes mean concentration ratios 
between GABA and tCr, CRLB values and absolute uncertainties for GABA 
and tCr at six different brain regions for the two different acquisition 
approaches. Measured spectral SNRs are also summarized in Table 3.1.
Software v18.11.6 (MedCalc Software bvba, Ostend, Belgium) was used to 
compare the raw GABA concentrations (determined by LCModel analysis) 
acquired by the two acquisition approaches over all voxels. 
Potential MM contributions in the edited 3 ppm peak of the MEGA 
approach were also approximated by amplitude ratios between the fitted 
GABA line by LCModel and the acquired GABA+ peak at 3 ppm.
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Figure 3.2. (A) Six spectroscopy voxel positions: anterior cingulate cortex (AC: red), dorsolateral 
prefrontal cortex (DLPFC: orange), motor cortex (MC: yellow), occipital cortex (OC: purple), 
posterior cingulate cortex (PC: green), and precuneus (PRC: blue). on the GM (gray) and WM 
(white) map. (B) Example results of the LCModel analysis for the MEGA-sLASER (left) and 
the sLASER (right) that were acquired with the interleaved acquisition from a single 
voxel at PRC. The fitted line is plotted in red and residual signal (the difference between in-
vivo and fitting lines) is plotted at the top. 
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Figure 3.3. shows the correlation between GABA/tCr and GM volume 
fraction in the spectroscopy voxel estimated with the two different 
acquisitions after T2 correction between sLASER (TE = 38 ms) and MEGA-
sLASER (TE = 80 ms). We found a linear correlation between the GABA/
tCr concentration ratio and GM tissue distribution (linear regression line: 
and
%). In addition, these regression lines were almost identical for the two 
methods. This result shows a large dependence of measured GABA 
concentration on GM volume fraction, independent of the two acquisition 
methods. On the assumption that CSF does not contain significant 
quantities of metabolites (Joanna et al., 1993), estimated percentage 
GABA distributions in the GM and WM using the linear regression lines were 
(GM%: WM%) 86%: 14% for sLASER and 93%: 7% for MEGA-sLASER,  very 
much in line with the literature values for the relative distribution 
between GM and WM (Bhattacharyya et al., 2011) 
Figure 3.3. Correlation between GABA/tCr and GM volume fraction in the spectroscopy 
voxel measured by two different approaches (blue: TE = 38 sLASER, gray: TE = 80 MEGA-
sLASER) across all examined voxels after the T2 correction. GABA concentration was in 
directly proportional to the GM tissue fraction. The linear regression lines of these two 
methods are almost identical. Equations of the linear regression lines 
were        ,and                                        ,unit(%)  
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We also found similar GABA to tCr ratios acquired with the two methods 
for each voxel (Figure 3.4A). Error bars indicate 95 % confidence intervals. 
Regional GABA concentrations showed statistically significant differences 
between group means as determined by a one-way ANOVA (F(5,36) = 
0.302, p = 0.019) for the sLASER method, and (F(5,36) = 6.015, p < 0.001) 
for the GABA editing method. OC, PC, and PRC showed similarly high 
mean GABA/tCr ratios as compared with the other three regions: AC, 
DLPFC, and MC.
Figure 3.4. GABA/tCr comparisons after considering both the GM and WM volume weighting 
and the T2 relaxation times of GABA and NAA. T2 correction factor for TE=80 MEGA-sLASER was 
1.488 or GABA/tCr. Ater applying this actor, we ound no statistically significant difference 
in GABA/tCr ratio between the two methods. P-values were above 0.05 for all regions. Error 
bars indicate 95% confidence intervals. 
Figure 3.5 shows CRLB comparisons of GABA (A) and tCr (B), estimated 
by the two different acquisition strategies. For both metabolites, the 
MEGA-editing approach showed slightly better spectral fitting quality 
than that of the non-editing acquisition approach according to CRLB 
for all regions examined. Error bars also indicate 95% confidence 
intervals.
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Figure 3.5. CRLB comparison of (a) GABA and (b) tCr between sLASER and MEGA-sLASER for 
the six brain regions examined. Error bars indicate 95% confidence intervals, in accordance 
with table 3.1.
The Bland-Altman plot in Figure 3.6 shows the mean bias ± SD with 95 % 
confidence intervals between the sLASER and MEGA-sLASER results as 
0.06 ± 0.73 (blue line), and the limits of agreement were −1.36 and 1.50 
(brown lines).
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Figure 3.6 Bland-Altman plot of the GABA concentration from the interleaved measurements 
using the semi-LASER and MEGA-semi-LASER approaches afterthe LCModel analysis. The blue 
horizontal line shows a mean value and two brown lines show ± 1.96 * SD with 95 % 
confidence intervals (green) across all measurements.
One example of the GABA edited spectrum (gray) with metabolite fitting 
lines: GABA (red), NAAG (green), NAA (purple), Gln (yellow) and Glu 
(blue), which were estimated from LCModel is shown in Figure 3.7. 
GABA estimation is clearly determined by the fit to the 2.28 ppm peak. 
Pure GABA accounts for 47.21 ± 17.04 percent of the total 3 ppm signal, 
calculated as the ratio of the LCModel GABA fitted line at 3 ppm to the 
total measured 3 ppm peak averaged over all subjects.
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Figure 3.7. one example o GABA edited spectrum (gray) with metabolite fitting lines: GABA 
(red), NAAG (green), NAA (purple), Gln (yellow), Glu (blue), Glu (blue) and MM (orange), 
which were estimated from LCModel. The top panel indicates residual, which is a difference 
between in-vivo and fitting lines. Directly observable GABA-2CH2 resonance at 2.28 ppm 
plays an important role in the GABA quantification with spectral fitting. GABA estimation is 
limited by the 2.28 peak, which is the true GABA. It prevents over-estimating GABA by co-
edited macromolecule. Note that the bottom part of the NAA signal is truncated in this figure
3.4 Discussion
The interleaved sequence, which we implemented in this study, 
provides simultaneous MEGA-editing and non-editing acquisitions in 
a single sequence. By acquiring concurrently, the interleaved 
acquisition balances any instability across the two techniques. 
Therefore, we could avoid potential problems of registration, motion, 
B1-inhomogeneity or different shim quality that may have occurred if we 
would have acquired sequentially. It is widely known that the adiabatic RF 
pulse based sLASER sequence has the advantage of the less level of 
CSDE in comparison to the PRESS sequence at the ultrahigh field 
(Scheenen et al., 2008a) owing to the use of adiabatic refocusing 
pulses. The sequence used in this study had a maximum CSDE of 8.4% 
(Rohani Rankouhi et al., 2018).
After applying the T2 correction factor, which compensates the different 
TEs, the GABA/tCr ratios for the two acquisition techniques did not differ 
significantly. From the fact almost all difference  values  are  within  the  
confidence  limits,  and  the  p-value  is greater than 0.05, we conclude 
that there was no significant difference between the GABA acquisition 
methods (see Figure 3.6). 
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In addition, the uniform distribution of difference values shows that 
there is no systematic bias between the two methods (calculated bias = 
0.01). Judging from the results of the linear regression lines (see Figure 
3.3) and the Bland-Altman analysis (see Figure 3. 6), the two different 
approaches showed similar consistency in terms of the GABA 
estimation across the brain regions in combination with proper 
compensation steps.
3.4.1  Regional GABA Concentration
Even though the main purpose of this study was to compare the two 
methodological approaches in combination with LCModel analysis, we 
were also able to compare GABA concentrations across different 
brain regions. As we mentioned in the Introduction, it is widely 
known that GABA is mostly concentrated in GM (approximately 90% in 
GM and 10% in WM). Not only spectroscopy studies (Bhattacharyya et al., 
2011; Choi et al., 2006; Ganji et al., 2014) but also an ex-vivo study (Perry 
et al., 1971a) obtained similar GABA distribution ratios between GM 
and WM. Chen, et al (Chen et al., 2016) reported that GABA 
concentration linearly increased with GM volume fraction for one of the 
brain regions we also studied (AC). In our result, as we can see in Figure 
3.3, GABA concentrations were largely driven by the GM tissue fraction. In 
addition, estimated GABA distribution ratios in the GM and WM by the 
linear regression lines are in close agreement with the literature value. 
This result confirms that GABA is heavily concentrated in GM, and 
highlights the importance of the tissue volume correction for GABA 
quantification (Mikkelsen et al., 2016a).
In addition to the current study, other studies, which investigated 
regional GABA concentration differences while accounting for tissue 
volume variations, found differences in the regional GABA level. However, 
there is some inconsistency in the literature. For instance, Ganji, et al 
(Ganji et al., 2014)  reported higher concentrations of GABA in the 
frontal lobe than in the OC at using PRESS (TE = 92 ms) at 7 T. Öngür, et 
al (Öngür et al., 2010) found higher GABA/Cr ratio in a frontal region 
(AC) than in an occipital region (parieto-occipital cortex) measured with 
the MEGA-editing method at 4 T. On the other hand, Bhagwagar, et al 
(Bhagwagar et al., 2008) found higher GABA/Cr ratio measured with 
MEGA-editing in the occipital region (OC) than that in AC. Durst, et al 
(Durst et al., 2015) also reported higher GABA in OC than in frontal lobe 
using 3 T MEGA-PRESS. Van der Veen, et al (Veen and Shen, 2013) 
similarly  found  higher  GABA  concentration  in  the  OC  than that of the 
A comparison of sLASER and MEGA-sLASER using simultaneous 
interleaved acquisition for measuring GABA in the human brain at 7T
59
3
the anterior area (c. f., MPFC) with the MEGA-editing method comparing 
two voxels in frontal and occipital lobes. Van der Veen, et al (Veen and 
Shen, 2013) selected voxels that had the same GM and WM tissue 
volume to exclude tissue volume effects. They proposed therefore that the 
difference  should  be  attributed  to  factors  other  than  GM volume. The 
trend in our data is in accordance with that of the latter studies (Bhagwagar 
et al., 2008; Durst et al., 2015; Veen and Shen, 2013). 
Recent molecular Imaging studies, which quantified GABAA receptor 
using positron emission tomography (PET) with 11C flumazenil (D’Hulst et 
al., 2015; Richardson et al., 1996), and single-photon emission computed 
tomography (SPECT) with 123I-iomazenil (Nagamitsu et al., 2016) have 
visualized GABAA receptor densities in the human brain. These reports 
have shown not only that the GABAA receptor is more heavily concentrated 
in GM, but also its density in posterior brain areas is higher than that of 
anterior areas. This supports our finding that GABA concentration in 
posterior regions such as OC, PC, and PRC showed higher GABA levels than 
those of anterior regions: AC, DLPFC, and MC.
3.4.2  MM contamination
We found no statistically significant difference for the quantified GABA 
concentrations with LCModel between two acquisition techniques. Our 
finding could potentially be explained by one of two possibilities: The 
LCModel fitting result of the non-editing spectrum also contains MM 
contamination, or LCModel efficiently quantifies the GABA signal from the 
GABA edited spectrum without the interference of the co-edited MM. 
LCModel estimates MM and lipid signals at each fixed chemical shift 
location with non-parametric spectral models including a smoothing 
B-spline as a baseline (Provencher, 1993). Because these MM and lipid
signals are not only measured values but also part of the formulaic model,
these quantification approaches still risk over-, or under-estimating
metabolic concentrations in the co-edited signal. It is quite challenging to
determine from our LCModel quantification results of sLASER whether the
estimation of GABA is contaminated by MM. However, we can assume the
presence of MM contamination in the MEGA-sLASER spectra. In contrast
to MM and lipid signals, metabolic signal quantification uses parametric
spectral models, which are included in a basis set. LCModel finds metabolic
concentrations by changing the amplitudes of simulated metabolic models
with their lineshapes unchanged. Therefore, all resonances of GABA
also play an important role in solving the optimization problem.
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In our spectral fitting results, we found that the directly discernible 
2.28ppm GABA signal was essential for distinguishing the GABA signal 
from GABA+ (see Figure 3.7). GABA estimation was largely determined by 
the size of GABA-2CH2 resonance at 2.28 ppm. Because the 2.28 ppm 
region is not related to the co-edited MM, the visible GABA resonance at 
2.28 ppm represents an uncontaminated GABA signal. This result 
suggests that GABA quantification with spectral fitting is able to separate 
pure GABA from GABA+ provided that the 2.28 ppm GABA resonance is 
also recorded. Previous studies by Ganji, et al (Ganji et al., 2014) and 
Choi, et al (Choi et al., 2012a) also highlighted the significance of this 
GABA-2CH2 resonance in terms of the spectral fitting procedure. 
LCModel provides a GABA-editing exclusive control file  called ‘mega-
press-3’ (Provencher, 2016). This setting excludes quantification of the 
baseline and MM signals assuming baseline and MM signals are identical 
between MEGA-on and -off spectra, and that they hence cancel in the 
subtraction. Since this setting mainly attempts to estimate the 3 ppm 
peak as GABA+, this necessarily overestimates the GABA concentration 
as co-edited MM will not be eliminated. Therefore, we did not use this 
approach.
We corrected for T2 relaxation using the T2-value of 63 ms taken from 
the study by Intrapiromkul, et al (Intrapiromkul et al., 2013). After 
correction the values obtained were similar between the two methods 
(see Figure 3.3 and Figure 3.4A). This consistency strongly supports the 
correctness of the T2-value used, and also that the analyses have yielded 
results without MM contamination. Our estimate that MM constitutes 
approximately 53% of the signal at 3 ppm is at the upper limit of, but 
not inconsistent with previous literature values 44% (Rothman et al., 
1993), 41 - 49% (Shungu et al., 2016), and 52-57% (Mikkelsen et al., 2016b) 
3.4.3  Spectral fitting quality
Since the thresholded CRLB estimation may cause a bias (Kreis, 2016), 
we included all GABA and tCr results. We also compared absolute 
uncertainties for the GABA estimation for both acquisition methods. As a 
result, we found that CRLBs and absolute uncertainties of estimated 
GABA for the MEGA-editing method are lower than those for non-
editing acquisition method for all six regions (see Table 3.1 and Figure 
3.5A). 
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3.5 Conclusion
This study compared GABA concentration for six different brain regions 
with the non-editing spectral acquisition approach and the GABA editing 
approach using a single interleaved sequence acquisition. The simultaneous 
acquisition of sLASER and MEGA-sLASER minimized differences in confounds 
which could have occurred in individual acquisitions. Our finding confirms 
that GABA is heavily concentrated in GM. Therefore, regional GM volume 
is an important contributor to measured GABA concentration variation. 
In addition, the ability to reliably measure the GABA resonance at 2.28 
ppm would appear to lead to accurate estimates of GABA concentration 
without MM contamination. A similar concentration of GABA signal 
measured with the two methods for each voxel was obtained after 
correction for T2, showing that the two acquisition strategies are both 
reliable and have a similar accuracy to measure GABA. However, The 
GABA-editing approach was superior in terms of precision, as assessed 
by lower CRLB values.
Compared with the non-editing acquisition, the GABA editing method 
provides a much simpler spectral pattern with only six metabolic signals 
present, that are relatively well separated. This explains why the spectral 
fitting precision of the MEGA-editing results for  estimating  GABA is 
superior to that of the sLASER result, despite the editing method 
eliminating also a number of lines from the GABA spectrum. MEGA-
sLASER and sLASER showed similar CRLB values for tCr (Figure 3.5B) 
which is unsurprising given that the tCr concentration of the MEGA-sLASER 
was estimated from the MEGA-off spectra using a non-editing 
acquisition. The reasonably good CRLB values of tCr for both 
approaches confirm that spectral quality and spectral fitting quality with 
LCModel were good enough for accurate quantification.

CHAPTER 4.
Optimal phased-array signal combination strategies from 
separate coil elements for GABA spectroscopy at 7T
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Abstract
The use of phased array coils for signal reception can increase the signal to noise ratio 
(SNR) of single voxel spectroscopy. To take full advantage of the phase arrayed coil, 
an optimal signal combination strategy is required. This is especially important for 
detecting low concentration metabolites such as gamma-aminobutyric acid (GABA). In 
this study, we modified coil combination methods by excluding the contribution from 
coils with low signal in order to maximize SNR. Two representative GABA acquisition 
methods: the non-editing and GABA editing approaches, were used to acquire single 
voxel spectroscopy data from twenty healthy volunteers using a 32-channel phased 
array receiver coil at 7 T. When the number of channels was reduced and an optimized 
coil weighting method used, we found a reduction in ghost artifact level, and an 
improved SNR in comparison with the conventional coil combination method. 
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4.1  Introduction
The phased-array receiver coil is standard equipment in the modern 
magnetic resonance scanner, as it can both be used to increase the signal 
to noise ratio and decrease scan time (Hardy et al., 1992; Roemer et al., 
1990). To take maximum advantage of a phase arrayed coil, an optimal 
signal combination strategy is required. Since the signal weighting method 
was proposed with 4 channels (Roemer et al., 1990), various signal 
combination schemes have been proposed for proton spectroscopy, 
which combine separate signals from each coil element in the time 
domain (Brown, 2004; Erdogmus et al., 2004; Roemer et al., 1990), or the 
frequency domain (Hall et al., 2014; Wald et al., 1995). Among these, the 
signal weighting method (Brown, 2004) is now widely accepted as a 
default method of the commercial MR scanner due to its speed and 
simplicity (Rodgers and Robson, 2016). However, because this method 
uses signal intensities as assessed by the dominant signals (e.g., N-
acetylaspartate (NAA), or weakly suppressed water signal) as weighting 
scores, it is not necessarily optimal for low SNR metabolites such as 
gamma-aminobutyric acid (GABA) where sensitivity is a primary concern. 
In comparison with imaging, single voxel spectroscopy acquires the signal 
from a relatively small voxel. Therefore, all channel elements do not 
contribute equally. Especially, in the situation that the voxel is located at 
the periphery, high sensitivity signal is only recorded at a limited 
number of coils, that are positioned close to the voxel, whereas 
remote coil elements detect signals with a low SNR level. More remote 
coils may only add noise to the spectrum. Therefore, in this study, we 
extended previously proposed coil combination strategies (Brown, 
2004; Erdogmus et al., 2004; Hall et al., 2014; Roemer et al., 1990; 
Wald et al., 1995) in order to maximize SNR by excluding low SNR data. 
We compared the use of an optimal number of coils with the 
conventional approaches, which use all coil data, for two 
representative GABA measurement techniques: GABA editing using 
MEGA (Mescher et al., 1998; Mescher et al., 1996; Rothman et al., 1993) 
and a non-editing acquisition where spectral fitting is used to assess the 
GABA concentration. 
Since GABA quantification requires spectral fitting steps in the time 
(Poullet et al., 2007) or frequency (Provencher, 1993) domains in order 
to resolve GABA accurately from overlapped signal (e.g., creatine (Cr), 
glutamate (Glu) and co-edited macromolecule (MM)), spectral fitting 
quality should also be taken into account in  evaluating  the  optimal coil 
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combination strategy for GABA. Therefore, we also evaluated coil 
weighting methods on the basis of the spectral fitting precision as well 
as the SNR improvement and investigate which signal combination 
method is optimal in terms of GABA quantification using LCModel 
fitting (Provencher, 1993, 2001).
4.2  Materials and Methods
4.2.1  Data Acquisition
A 7 T whole body system (Magnetom, Siemens, Erlangen) equipped 
with a 1 Tx-birdcage/32 Rx-loops array (Nova medical, Wilmington, MA) 
was used for MRI and MRS acquisitions. First, T1 weighted images with a 
three dimensional MPRAGE (Magnetization Prepared Rapid Acquisition 
Gradient Echo) sequence were collected for voxel positioning with the 
following parameters; matrix size = 256 * 256 * 256, 1 ml isotropic voxel 
without slice spacing, flip angle (FA) = 6°, repetition time (TR) = 2300 ms, 
echo time (TE)= 1.35 ms, and inversion time (TI) = 1100 ms. 
FASTESTMAP (Gruetter and Tkáč, 2000) was used to shim the spectroscopy 
voxel before the spectral acquisition. MEGA-sLASER (Andreychenko et 
al., 2012) and sLASER (Scheenen et al., 2008a; Scheenen et al., 2008b) 
sequences were employed to acquire single voxel spectroscopy data from 
8 ml isotropic voxels at occipital cortex of 20 healthy volunteers (11 males 
and 9 female subjects; 27.2± 7.23 years old) with following parameters: 
MEGA-sLASER: TE = 80 ms, TR = 4500 ms and number of averages = 64, 
and sLASER: TE = 38 ms TR = 4500 ms and number of averages = 64. 
Weak water suppression was used for both acquisition approaches. 
4.2.2  Combination strategies
Combination methods make a weighted linear sum of multiple signals. In 
order to align spectra, a phase correction step was performed to maximize 
the SNR (Brown, 2004). Combined signal  from individual signal  of 
the n-channel receiver coil after phase correction can be written as:
(4.1)
(4.2)
where A is signal amplitude;  the angular frequency;  the phase;   a 
weighting vector and n the coil number. Various methods for obtaining 
the values of w will be described below. All signal combination steps 
were processed using custom written  scripts in  Matlab  (version. 2016b,
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Mathwork, Natick, MA). We used a measurement history file, called 
TWIX in the Siemens system, which stores raw data from each coil 
element. First, we performed the 0th order phase correction to align all 
spectra individually over the iteration and channel in the time domain, 
and then combined the signals using the strategies described below. 
The following description describes the coil combination schemes used 
in this study.
1. Signal weighting method
The signal weighting method (Hardy et al., 1992; Roemer et al., 
1990) is the most commonly used approach due to its simplicity and 
accuracy. Subsequently, Brown (Brown, 2004) proposed another signal 
weighting algorithm, that uses the conjugate value of the first time point 
of the time domain signal since the first time-domain point represents 
both the phase angle and the coil sensitivity. This method which we 
employ, performs the phase correction and the weighting 
simultaneously by multiplying the conjugate number as a weighting 
score with the time domain signal. The combined signal S(t) from the 
individual signal  by the signal weighting combination step can be 
written as:
            (4.3)
where,  denotes a conjugate value of the first time point from nth coil 
data. 
2. Signal to noise (SNR) weighting and signal to noise squared (SN2R)
weighting methods
This SNR weighting method uses the SNR of a certain peak (e.g. NAA or 
residual water), in the frequency domain signal as a weighting coefficient 
(Deelchand et al., 2010; Wald et al., 1995) to compensate noise variations 
between channel elements on the assumption that the noise of each coil 
element is not correlated. Spectra are combined with the weighted sum by 
the Eq. 4.2. Hall, et al (Hall et al., 2014) latterly proposed the SN2R 
combination method. They showed the SN2R weighting method 
slightly improved the spectral SNR in comparison with the SNR 
weighting method. For the SNR weighting, the SNR of the targeted 
peak in the frequency domain provides the weighting coefficient. For 
the editing approach, SNR of the 3 ppm peak, which is widely referred to 
as GABA plus (GABA+) due to the co-edited MM (Mescher et al., 1998; 
Mullins et al., 2014), was used as the target peak in the GABA edited 
spectrum. 
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As GABA is not discernible in the non-editing acquisition spectrum, the SNR 
of GABA could not be used to give the weighting coefficient. Instead, the 
SNR of the 3 ppm peak, which 67is composed of total Cr (tCr: Cr + 
phosphocreatine (PCr)) and GABA was used. The SNR was calculated as the 
ratio of the peak amplitude to the standard deviation of the white noise 
area in the range 7 – 9 ppm. For the SN2R method, the same approach was 
used as the SNR weighting method except for the fact that the weighting 
coefficient is the SN2R of the targeted peak. 
3. Singular value decomposition (SVD) method
The SVD method (Erdogmus et al., 2004) separates the metabolite 
signal from noise on the assumption that the first singular value is 
an ideal spectrum without noise, and noise is uncorrelated between 
channels. The principal signal component was extracted from noise by 
the noise covariance matrix, which follows a multivariate normal 
distribution. The SVD of the noise decorrelated signal S (assuming the 
m*n matrix, where m: channel number and n: spectral resolution) is the 
factorization:
  (4.4)
in which, U is an m*m unitary eigenvector matrix of noise covariance,  , 
is an m*n diagonal matrix, and VT is an n*n unitary matrix, and the 
conjugate transpose of V. After SVD, the first principal column of VT is 
considered as an optimally combined signal. The noise covariance matrix 
was computed by white noise in the range from 2200 to 2500 Hz in time 
domain signal. 
4.2.3  Coil combination with the reduced number of channels
In this study, we modified the above mentioned coil combination methods 
to only use the most sensitive coil data. For the signal weighting method, 
we sorted all coil data by the magnitude of the first data point in 
descending order and iterated the weighting step until the combined 
signal reached the maximum SNR. For the SNR and SN2R weightings, 
we sorted all coil data by the SNR of the 3ppm peak. For SVD, we also 
iterated SVD steps from the highest magnitude coil in the same way. 
4.2.4  Quantification and Evaluation
LCModel (ver. 6.3-1L, Stephen Provencher Inc, Oakville, Ontario, Canada) 
was used to quantify metabolite concentration and the Cramér-Rao lower 
bound (CRLB) as  an  estimate  of  the goodness  of  fit.  The  basis-set  for  
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LCModel quantification includes 20 metabolites: aspartate (Asp), 
ascorbate (Asc), glycerophosphocholine (GPC), choline (Cho), 
phosphocholine (PCh), Cr, PCr, GABA, glucose (Glc), glutamine (Gln), 
Glu, glycine (Gly), glutathione (GSH), myo-inositol (mI), lactate (Lac), 
NAA, N-acetyl aspartyl glutamate (NAAG), phosphoethanolamine (PE), 
scyllo-inositol (Scyllo) and taurine (Tau) for analyzing the sLASER 
acquisition, and six edited metabolites: GABA, Glu, Gln, NAA, NAAG and 
GSH for the MAGA-sLASER. These parametric models were 
simulated using the NMRSIM module of the TOPSPIN suite 
(Version 3.6, Bruker, Rheinstetten, Germany). In order to avoid an 
over-estimation of GABA due to the co-edited MM for the GABA editing 
approach, we included one Lorentzian lineshape singlet peak as an 
MM signal at 3 ppm in the MEGA-sLASER basis set. Estimated 
metabolite concentrations that related to the total NAA (tNAA: NAA + 
NAAG) and CRLBs were compared between weighting strategies. 
The combined spectra for different weighting approaches was evaluated 
by the SNR of the 3 ppm peak and the spectral fitting quality according to 
CRLB for the non-editing and GABA editing spectra. In order to avoid 
differences due to phasing between spectra, the spectral SNR was 
calculated in the magnitude mode. For the obtained results, a two-way 
analysis of variance (ANOVA) compared the group mean of the SNR for 
3 ppm peaks and the CRLB values for the GABA estimation across the 
weighting methods using SPSS (ver. 22, IBM, Armonk, NY) in order to 
explore the main effect of coil number and weighting schemes and the 
interaction effect between them on the SNR and spectral fitting quality. 
The null hypothesis was that there would be no difference between coil 
number and weighting methods. A p-value of less than 0.05 was 
considered statistically significant.
4.3  Results
Figure 4.1 demonstrates SNR changes of the 3ppm peak with the number 
of coils used for the selective coil weighting from one representative 
subject. As coil numbers increase, the SNR of the 3ppm peak increases until 
a maximum is reached (red line). After adding data from the next coil, the 
SNR falls. This combination method selects the coil contributions which 
achieve the maximum SNR. However, for SVD, the maximum SNR, which 
was achieved with the reduced coil number is identical to that with full coil 
numbers. The average numbers of coils used for the different weighting 
techniques were: signal weighting: 11.4 ± 2.3, and 9.5± 1.7; SNR weighting: 
10.2 ± 3.6, and 8.5± 2.1; SN2R weighting: 7.2 ± 5.2, and 10.7± 5.3; SVD 
weighting: 28.3 ± 3.2 and 28.4 ± 2.5 for the non-editing and GABA editing 
approaches, respectively. 
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Figure 4.1. SNR changes of the 3ppm peak as a function of the number of coils used for the 
signal for different weighting schemes: Signal (A), SNR (B), SN2R (C), and SVD (D) coil weighting 
methods from one representative subject for the non-editing acquisition. As the number 
of coils increases, the SNR of the 3ppm peak reaches maximum SNR at a certain coil 
element (red horizontal line). After adding the coil data, the SNR starts to deteriorate. 
However, the SVD method achieved when 22 coil date was used and its SNR is identical to 
that with all coil signals. 
Figure 4.2 compares spectra that were combined with four different 
weighting methods from one exemplary subject for the non-editing 
acquisition (A) and GABA editing (B) methods when all coil signals 
(black) or selected coil signals for maximum SNR (blue) were used. The 
Gray line in the top panel of each fit indicates the difference between the 
black and blue signals. The non-editing acquisition spectra show no 
significant macroscopic differences in the metabolite area between 
weighting methods. However, when the proposed method was used that 
utilizes only good SNR signals (see blue lines), we found that the ghost 
artifact was effectively eliminated for the signal, SNR and SN2R 
methods. For the SVD method, the two approaches showed identical 
results. For GABA editing spectra, frequency domain methods that use 
GABA signal as a weighting coefficient showed a clear GABA+ signal at 3 
ppm in comparison with the signal weighting and SVD methods. SVD 
showed a relatively lower noise level in comparison with other spectra 
for both acquisition strategies. Note that this example case is not the 
best spectrum we acquired. We selected this case since it shows a 
typical ghost artifact reduction and qualitative differences of the 3ppm 
signal for different weighting schemes.
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Figure 4.2. Comparison of the combined spectra processed with the four different strategies 
for the non-editing (A) and GABA editing (B) approaches. When all coil data (black) and the 
reduced number of coil data (blue) were used. The non-editing acquisition spectra show no 
significant macroscopic differences between weighting methods, whereas, the SNR and SN2R 
methods showed improved SNR of the 3ppm signal for the GABA editing approaches. Note that 
in order to avoid spectral pattern differences due to the different phase angle between spectra, 
this figure compares the magnitude mode spectra 
Measured SNR of the 3 ppm peak for both acquisition approaches: the 
non-editing (A) and GABA edited (B) acquisitions after weighting with each 
combination method are shown in Figure 4.3. When all coil data were used, 
the non-editing and GABA edited spectra showed a similar pattern in that 
the SVD weighting method showed a relatively higher SNR and the signal 
weighting showed a lower SNR for the 3 ppm peak. When only the high 
SNR coils were used, all four methods showed similar SNR levels for the 
non-editing approach whereas the SN2R results showed the highest SNR in 
comparison with other three methods for the GABA editing approach.
Figure. 4.3. Boxplots compare SNRs of the 3ppm peak in the non-editing (A) and GABA editing 
(B)approaches. In both cases, we found a somewhat higher SNR for the SVD weighting approach 
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in comparison with the other three approaches when we used all coil data. However, when only 
high SNR coil data were used, all combination approaches showed statistically similar SNRs for 
both acquisition approaches. Note that the horizontal lines in the middle are median values and 
cross marks are average values. 
The ANOVA analysis showed that for the non-editing acquisition approach, 
the main effect for the channel number yielded an F ratio of F(1, 133) = 9.20, 
P=.003 indicating a significant difference between the full coil approach 
(147.41 ± 26.64) and reduced coil approach (160.78 ± 26.04). The main effect 
for weighting scheme yielded an F ratio of F(3, 133) =.304, p=.822 indicating 
that the differences are not significant between weighting schemes: signal 
(152.66 ± 25.42), SNR (154.24 ± 27.31), SN2R (153.11 ± 25.11), and SVD 
(165.33 ± 27.30). The interaction effect also was not significant F(2, 133) 
=.222, P=.801. 
For the GABA editing approach, the main effect for the channel number 
yielded an F ratio of F(1, 133) = 21.828, P<0.001 indicating significant 
difference between the full coil approach (10.85 ± 3.33) and reduced coil 
approach (13.62 ± 3.92). The main effect for weighting scheme yielded 
an F ratio of F(3, 133) = 7.828, p<0.001 indicating a significant difference 
between weighting schemes: signal (10.28 ± 2.72), SNR (12.07 ± 3.72), 
SN2R (14.78 ± 3.63), and SVD (15.05 ± 3.91). The interaction effect was not 
significant F(2, 133) =.167, P=.847. 
Combined signals obtained by the four different combination methods 
were compared with a corresponding fitting line by the LCModel analysis 
for the non-editing (Figure 4.4A and 4.4B) and GABA editing (Figure 4.4C 
and 4.4D) approaches when all coil data were used (Figure 4.4A and 4.4C) 
and only high sensitivity coils were used (Figure 4.4B and 4.4D). For the non-
editing acquisition, there are not any clearly visible differences in fitted 
lines between different weighting results. However, For the GABA editing, 
the fitted line of the SNR weighted method showed a doublet lineshape 
which is consistent with that expected for edited GABA signal at 3 ppm. In 
the combined spectra by the SNR and SN2R methods, we could also find a 
clear GABA signal at 2.28 ppm which is a partially discriminable. In addition, 
fitted lines showed good agreements with these signals. (highlighted in 
green in Figure 4.4C and 4.4D) 
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Figure 4.4. Comparison of the spectral fitting line (red) estimated by LCModel analysis for the 
non-editing (A and B) and GABA editing (C and D) approaches with corresponding 
underlying spectra (black) from the exemplary subject of Figure 4.2. When only high SNR coils 
were used, all combination methods showed less noise for both acquisition methods (B and D). 
There are not any visible differences in fitted lines between different weighting results for the 
non-editing acquisition. However, For the GABA editing, frequency domain methods: SNR and 
SN2R weighting, showed clear 3 ppm signal as compared with that of the time-domain 
methods: signal and SVD methods. In addition to the 3ppm signal, partially discriminable 
GABA signal at 2.28 ppm showed a good agreement with the fitting lines (highlighted in 
green) 
Figure 4.5 compares GABA concentration ratios relative to the 
tNAA concentration and CRLB of GABA that were estimated by the 
LCModel analysis across the weighting methods of the non-editing (A) 
and GABA editing (B) acquisition approach with an error bar of the 
95% confident interval. For both approaches, there were no apparent 
differences in estimated GABA concentration between weighting 
methods. However, we found the lowest fitting error for the SVD 
weighting as compared with the other three approaches, which were 
similar when all coil data were used. However, when high SNR coil data 
were only used, all other methods showed improved fitting precisions 
and the SN2R methods showed the lowest CRLB. 
For CRLB of the GABA editing, two-way ANOVA results showed 
that reduced coil number and weighting schemes were significantly 
improved spectral fitting quality for GABA (F(3, 133) = 16.420, 
p<0.001 for coil number; F(3, 133) = 3.814, p=.012 for weighting 
scheme). However, there was no significant interaction between the 
effects of coil number and weighting methods, F(1, 133) =.035, p = .966. 
We could not find significant differences in the estimated GABA 
concentration across the coil number and the weighting schemes. 
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Figure 4.5. Estimated GABA concentration ratio related to tNAA (left) and CRLB (right) 
estimated by LCModel analysis for the no (A) non-editing the GABA editing (B) acquisition 
results. There were no apparent differences in estimated GABA concentration 
between weighting methods. For the fitting precision, ????SVD method showed good fitting 
reliability for GABA when all coil data used. Whereas, when high SNR coil data were only 
combined, all methods showed improved fitting precision. The SN2R method showed the 
lowest CRLB values for GABA. 
4.4 Discussion
4.4.1 Overview
This study proposed coil combination methods that exclude low SNR coil 
data in order to maximize the SNR of the combined spectrum and evaluated 
weighted spectra based on the SNR and the spectral fitting quality for GABA 
quantification. The SVD method that extracts the principal signal from 
the noise showed a good denoising effect and also completely removed 
the ghost artefact. Therefore, this combination method showed a good 
overall SNR as compared with other approaches for both GABA acquisition 
approaches. However, when only high SNR data were combined, the signal, 
SNR and SN2R methods also achieved a statistically similar SNR level to 
that of the SVD method. In addition to the SNR improvement, the high SNR 
coil combination methods also showed reduced levels of the ghost artifact 
that was present when all coil data were weighted. Improved spectral SNR 
resulted in improved fitting precision for estimating GABA. 
4.4.2 Coil weighting with high SNR data
Since our proposed approach finds the best SNR value by varying the 
number of coils considered, it guarantees the same or better performance 
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than that achieved by fully use of all coil information. If the coil design 
were perfectly optimized for the position of the selected voxel then the 
SNR of the combined signal should improve as the number of coils used 
increases. However, in realistic spectroscopy situations where a single 
phased-array coil is used for all voxel positions, if the SNR is too low, the 
effect of using some coils’ signals is to reduce SNR (see Figure 4.1). By 
excluding suboptimal coil data, the coil weighting method with the reduced 
coil number improved SNR of the combined spectrum. In comparison 
with the weighted signal with all coil data, results with the reduced coil 
approach showed less noise (see Figure 4.2). Accordingly, our proposed 
method achieved both the SNR and spectral precision improvements for 
the selected signal regardless of the acquisition and coil combination 
techniques. 
One point warranting further discussion is the SVD method. This method 
also achieved the maximum SNR when a reduced number of coils 
was used, however, this achieved SNR is identical to that achieved with 
all coil data. In addition, this method required a number of coils close to 
the maximum to accomplish the best SNR. From the fact that SVD 
extracts the principle data from noise, we can expect it to be less 
sensitive to the presence of additional noise. 
4.4.3 Non-editing acquisition
For the non-editing acquisition spectrum, since the 3 ppm peak, 
which was used to obtain the weighting coefficients, is still one of the 
highest concentrated signals, we found no significant differences in the 
spectral pattern in the metabolite area (see Figure 4.2A). Judging from 
the signal level at 4.2 ppm area, the SVD method effectively eliminated 
the ghost artifact which is a result of insufficient spoiler gradient 
performance for water suppression (Kreis, 2004). When all 32-channel 
data were used, the SVD method showed the best performance in terms 
of the SNR. However, the three other weighting methods: the signal, SNR 
and SN2R methods that showed inferior spectral SNR with 32 coil data 
combination, also improved to an SNR level similar to that of the SVD 
result, and their SNR levels were statistically comparable. From the two-
way ANOVA result, the reduced coil data approach played a more 
important role in improving SNR than the weighting schemes. 
Our results showed that there was no significant difference in the 
estimated GABA concentration and the corresponding spectral fitting 
quality across the weighting schemes and the coil numbers. As we 
mentioned earlier, since the 3ppm signal, which is used as a 
weighting  coefficient, is one of the highest peaks, weighted spectra 
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across the different weighting methods showed comparable spectral 
patterns. Accordingly, GABA estimation results were comparable. Even if 
the signal level at around 4.2 ppm area was different between weighting 
scheme and coil numbers, these differences had negligible impact on the 
GABA fitting since this this area is not related to the GABA resonances. 
An attempt to obtain coil weights that would yield a better result for 
GABA estimation would require LC Model analysis of individual coil data.
4.4.4 GABA editing acquisition
For the GABA editing spectra, the frequency domain approaches: SNR and 
SN2R weightings showed better delineated signals at 3 ppm in 
comparison with the time domain approaches: signal and SVD weighting. 
As compared with the time domain methods that used the total signal as 
a weighting co-efficient, the frequency domain methods directly use the 
GABA+ at 3 ppm. This necessarily resulted in somewhat different spectral 
pattern of the weighted line at 3 ppm between time and frequency 
domain methods. We found a clear 3 ppm signal by the frequency domain 
methods. Even though the GABA editing approach has lower artifact 
levels since the data subtraction can eliminate persistent artifacts, the 
SVD method still showed a superior performance for eliminating the 
ghost artifact at around 4.2 ppm area and for overall noise reduction as 
compared with the other methods. Accordingly, the SVD method showed 
a good SNR improvement for the measured 3 ppm signal in comparison to 
the signal weighting method. LCModel analysis found statistically similar 
GABA concentrations regardless of the weighting scheme (see Figure 
4.5B). When all coil data were combined, the SVD also showed a good 
spectral fitting quality for GABA. However, when high SNR data were only 
used, the SN2R weighting method showed the best precision across all 
weighting methods for the GABA fitting. Judging from the GABA 2CH2 
resonance which is partially discriminable at 2.28 ppm, combined in-vivo 
spectra by the frequency domain methods showed a good agreement 
with the fitting line. It is a clear evidence that the frequency domain 
methods are optimal for enhancing GABA for the GABA editing approach 
(see Figure 4.4C and 4.4D). From the fact that our two-way ANOVA results 
showed p-values which were smaller than 0.05 for both the SNR and 
CRLB, we could conclude that weighting methods and reduced coil data 
similarly played important roles to improve the SNR and spectral fitting 
precision for detecting GABA
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The conventional signal weighting method that uses the signal intensity 
of the time-domain signal as a weighting coefficient requires a dominant 
signal for accurate coil sensitivity estimation. Therefore, weak water 
suppression is recommended since this approach provides the coil 
weights without an additional water unsuppressed scan. However, an 
insufficiently suppressed water signal results in limited analog-to-digital 
(ADC) resolution and background noise. Moreover, the distorted baseline 
due to the deficient water suppression hinders accurate spectral 
quantification (Xi and Rocke, 2008). Whereas, since the frequency domain 
methods, including the selective coil weighting, do not require a 
dominant signal, as metabolite signals are directly used as weighting 
coefficients, and hence we can use strong water suppression. which can 
eliminate baseline distortion and spurious signals, and lead to the reliable 
and consistent detection of low concentration metabolites. 
4.4.6 Optimal method
In comparison with other weighting methods, the SVD method showed an 
exceptional de-noising performance by extracting pure spectroscopy 
signals from noise. This advantage has also been reported by previous 
studies (Nguyen et al., 2013). In the situation that an acquired in-vivo 
spectrum contains an artifactual signal that is induced by external factors 
such as a patient motion or an insufficient spoiler gradient performance, 
SVD method is a good choice in order to improve spectral SNR and the 
fitting precision. This study showed it is feasible to use the SVD method 
with computed noise covariance matrices calculated with an internal 
white noise area in the in-vivo spectrum. Since the acquisition bandwidth 
is normally much wider than the metabolite range, this additional 
information is easily calculable without requiring additional scan time for 
the noise relation matrix, which can also be acquired by turning off the 
gradient pulses. 
In accordance with a report by Hall et al (Hall et al., 2014), our result also 
showed that the SN2R weighting method is somewhat superior to the SNR 
method in terms of the SNR and GABA fitting precision improvement 
regardless of the number of the coil. The SN2R method in combination 
with the optimal coil selection showed a good GABA fitting reliability and 
SNR. Therefore, this approach is the preferred method for the GABA 
quantification for the GABA editing method.
4
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Abstract
Good B0 field homogeneity is considered an essential requirement to obtain 
high quality MRS data. However, B0 inhomogeneity can both broaden the 
linewidth and modify the lineshape. Deteriorated spectral quality due to the B0 
inhomogeneity hinders the precious spectral quantification. In this study, it is 
hypothesized that a realistic metabolite fitting model, which accounts for B0 
homogeneity on the basis of the water lineshape, will improve the consistency 
of estimation of metabolite concentrations across linewidths. In-vivo water 
suppressed/ unsuppressed single voxel spectroscopy signals were acquired under 
three different B0 field homogeneity regimes. Individual realistic basis sets were 
created for each acquisition. Frequency-domain spectral fitting with LCModel 
was used to quantify the metabolite concentrations with fitting uncertainties 
given in terms of the Cramer-Rao lower bound. The quantification results 
obtained using the water lineshape basis set yielded similar concentrations 
independent of linewidth, and showed a larger fitting error as the linewidth 
increased. The conventional approach, however, quantifies metabolite 
concentrations with greater variations despite showing a supposedly improved 
fitting quality. The water lineshape basis set achieved single voxel spectroscopy 
consistency that is less sensitive to the linewidth compared to the conventional 
spectral fitting method for the range of linewidths used in this study, but the 
precision deteriorated with worsening B0 field inhomogeneity. The beneficial 
effect was ascribed to a reduction in the number of degrees of freedom when 
using the water lineshape to generate the basis set.
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5.1  Introduction
Nuclear magnetic resonance (NMR) spectroscopy is a widely used non-
invasive technique to obtain biochemical information from the human 
brain. A fundamental objective of NMR spectroscopy is to measure 
metabolite levels within the voxel of interest (VOI). To this end, spectral 
fitting is commonly used along with various quantification algorithms 
(Provencher, 1993; Stefan et al., 2009; Wilson et al., 2011). Spectral fitting 
is challenging because metabolite signals have low concentrations and 
overlapping resonances. Moreover, unwanted factors, such as, B0 field 
inhomogeneity and eddy currents, distort experimental lineshapes while 
simultaneously reducing the signal-to-noise ratio (SNR) (Starčuk and 
Starčuková, 2016). Above all, a favorable B0 field homogeneity is an 
essential requirement because it directly affects the spectral lineshape. 
An inhomogeneous B0 field leads to SNR reduction. It can both broaden 
the linewidth and cause it to deviate from a Lorentzian form. Although B0 
field shimming is a pre-requisite for spectral acquisition, shimming is not 
invariably successful and the well-shimmed B0 field can be destroyed 
during the spectral acquisition. In particular, B0 inhomogeneity at the 
ultrahigh field (UHF, 7 T and above) is more severe owing to magnetic 
susceptibility effects. While spectroscopy at UHF shows improved 
performance in detecting metabolites with enhanced SNR and spectral 
resolution due to the high spectral dispersion and increased sensitivity 
(Uğurbil et al., 2003), robust shimming techniques, such as, higher order 
(Chang et al., 2018) and dynamic shimming (Lemke et al., 2015) 
methods have been proposed to address the poorer B0 inhomogeneity.
Most quantification methods assume that the ideal spectral lineshape 
can be represented using a Lorentzian function, which corresponds to 
exponential decay in the time domain. When experimental spectra 
have this ideal form with a narrow linewidth, the best quantification 
performance can be expected. Otherwise, additional steps are required 
to correct the lineshapes. Hitherto, there have been many attempts to 
convert arbitrary lineshapes into an analytic lineshape. We can broadly 
classify the previously proposed methods for correcting distorted 
lineshapes into those that use a reference lineshape and those that do 
not.
In the first approach, imperfect lineshapes due to B0 field 
inhomogeneity or eddy currents are corrected by de-convolving the 
reference lineshape in the time domain. Some representative methods 
include QUALITY deconvolution (De Graaf et al., 1990) and SPREAD 
(Dong and Peterson, 2009; Dong et al., 2014), which use field mapping 
for B0 field inhomogeneity, eddy current correction (ECC) (Klose,  1990) 
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for the distortion due to eddy currents, and QUECC, which is a 
combination of QUALITY deconvolution and ECC (Bartha et al., 2000) with 
advantages of both. 
As mentioned earlier, in the second classification, a reference lineshape is 
not required. Convolution with an additional parametric or non-
parametric lineshape is used. For instance, a lineshape obtained by the 
combination of Lorentzian and Gaussian lineshape functions, namely the 
Voigt lineshape, compensates the arbitrary lineshape (Marshall et al., 
1997), or model-free fitting methods (Provencher, 2001; Slotboom et al., 
1998) can be used to quantify metabolites using non-analytical 
lineshapes. The self-deconvolution method can in principle correct the 
distorted lineshape into an analytic form (Maudsley, 1995; Sima et al., 
2009). However, in these approaches, many degrees of freedom need to 
be regularized by additional strategies such as the regularized lineshape 
deconvolution(Zhang et al., 2011; Zhang and Shen, 2013), or the 
regularized semi-parametric model (Sima and Van Huffel, 2006)
As multiple factors can cause the experimental lineshape to deviate from 
a Lorentzian form, it is challenging to precisely correct the distorted 
lineshapes using regular mathematical algorithms. In addition, while 
correcting a resultant spectrum, there is a risk of losing critical spectral 
information and compromising the SNR. In this study, we hypothesize 
that a realistic metabolite fitting model considering the B0 homogeneity 
can be used to better estimate the metabolite concentration, thus 
obtaining fitting results that are less dependent on high B0 field 
homogeneity. Similar approaches that utilize water reference lines in 
order to compensate for B0 field inhomogeneity have previously been 
reported (Adalid et al., 2017; Li et al., 2015; Slotboom et al., 1998), the 
combination with LCModel, which is one of the most widely used 
quantification approaches, combined with human brain spectroscopy at 
7T remains unexplored. 
The aim of this study is to examine the degree to which the LCModel 
analysis is dependent on the linewidth, thus potentially improving 
spectral measurement in the presence of relatively broad spectral lines.
5.2 Materials and Methods
5.2.1  Basic concept of model fitting
The commonly used spectral fitting methods, which work in the frequency 
domain, such as, LCModel (Provencher, 2001), MIDAS (Maudsley et al., 
2006), TARQUIN (Wilson et al., 2011), TDFDFit (Slotboom et al., 1998), 
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and ProFit (Schulte and Boesiger, 2006), quantify the relative metabolic 
concentrations with similar algorithms that utilize time domain fitting 
models in order to exploit advantages of the time domain with regard to 
the frequency shift, eddy current, phase and lineshape (Bottomley and 
Griffiths, 2016). Assuming that the experimental signal is a linear 
combination of the metabolite signals, the metabolite levels are 
determined by combining each of the simulated signals. In the case of 
LCModel, which is used in this study, model spectra are fitted to each 
metabolic signal using the Levenberg–Marquardt non-linear fitting 
algorithm (Levenberg, 1944), which involves solving an optimization 
problem. The non-parametric baseline, lipid and macromolecule (MM) 
signals are additionally fitted using the cubic b-spline simultaneously.
The ideal spectral profile of each metabolite under given experimental 
conditions can be predicted using quantum-mechanical calculations 
(Bühl and van Mourik, 2011), and these are widely accepted as prior 
knowledge for spectral fitting. This is the basis of spectral fitting 
using simulated metabolite spectra, which has proven to be a 
powerful approach to quantify metabolite levels. However, thus far, 
potential spectral lineshape modifications due to B0 field inhomogeneity 
have been widely ignored in the spectral models, even though they may 
lead to inaccurate quantification. Instead, researchers widely depended 
on additional correction steps before fitting (De Graaf et al., 1990; Morris, 
1988; Ordidge and Cresshull, 1986), or an additional non-parametric 
function during spectral fitting procedures (Kreis et al., 2005; Maudsley, 
2004; Provencher, 1993; Slotboom et al., 1998; Soher et al., 1998). 
The water lineshape fitting method proposed in this study can be used to 
directly fit the in-vivo spectra with their corresponding realistic lineshape 
models. Several assumptions are made in this approach: 1) that 
the lineshapes of all the metabolites are identical, and are defined by 
the envelope of the free induction decay (FID), and are equal to that of 
the water signal. 2) The chemical shifts and J-coupling for each 
metabolite can be specified. From these assumptions, we designed 
realistic metabolite models that meet these conditions using the water 
lineshape. We then used a water lineshape basis set for spectral fitting 
without modifying the resultant in-vivo spectra. 
5.2.2  Data acquisition
MRI and MRS were performed on ten healthy human subjects 
(eight males; two females; 31.70 ± 4.99 years old) using a 7 T 
whole-body scanner (Magnetom,  Siemens,  Erlangen, Germany) with a 1 
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Tx-birdcage/ 32 Rx-loops array (Nova Medical, Wilmington, MA). Written 
consent was collected from each subject. The experimental protocol was 
approved by our institutional review board (IRB). 
T1 weighted images with 3D magnetization-prepared radio-frequency 
pulses and rapid gradient-echo (MPRAGE) (Mugler and Brookeman, 
1990) were acquired before the spectroscopic scan as an anatomical 
reference. Spectroscopy was performed at the occipital cortex using 
the semi-localization by adiabatic selective refocusing (semi-LASER) 
sequence (Scheenen et al., 2008a; Scheenen et al., 2008b) with the 
following parameters: 8 ml isotropic voxel volume; echo time (TE) = 38 
ms; repetition time (TR) = 4500 ms; number of averages = 64; bandwidth 
(BW) = 3500 Hz; and spectral resolution = 1024 data points. 
The MRS acquisitions were repeated under three different B0 field 
homogeneity conditions. The target ranges of the water linewidth under 
the three conditions were poor (30 to 40 Hz), medium (20 to 30 Hz), and 
good (10 to 20 Hz). The B0 field homogeneity was modified by repeating 
FASTESTMAP (Gruetter and Tkáč, 2000) until the water linewidth reached 
the target condition starting at the poor linewidth and then iterating the 
shimming procedure so that all three bins were measured. In the situation 
where the initial linewidth was narrower than the target range after the 
first attempt by FASTESTMAP, we manually adjusted the shimming by 
changing the first order linear gradients (A11, B11 and A10) and second 
order shim currents (A20, A21, B21, A22 and B22) by the same percentage 
to increase the linewidth. We acquired the corresponding water lineshape 
by turning off the water suppression in each shim case. For the water 
signal acquisition, the transmitter (TX) frequency was switched to water. 
The number of averages for water signal acquisition was 16. The 
remainder of the acquisition parameters (e.g., acquisition sequence, TE, 
TR, B0 field homogeneity, and spectral resolution) were kept constant 
between shim conditions.
5.2.3  Data processing
The model spectra of 22 metabolites: alanine (Ala), aspartate 
(Asp), glycerophosphocholine (GPC), choline (Cho), phosphocholine 
(PCh), creatine (Cr), phosphocreatine (PCr), gamma-aminobutyric acid 
(GABA), glucose (Glc), glutamine (Gln), glutamate (Glu), glycine (Gly), 
glutathione (GSH), myo-inositol (mI), lactate (Lac), N-acetyl aspartic acid 
(NAA), N-acetyl aspartyl glutamate (NAAG), phosphoethanolamine 
(PE), serine (Ser), scyllo-inositol (Scyllo), and taurine (Tau), which are 
typically detectable in the human brain using proton spectroscopy, 
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were created according to previously reported chemical shifts and 
coupling constants (Govind et al., 2015; Govindaraju et al., 2000). The 
NMRSIM module of the TOPSPIN suite (Ver. 3.6, Bruker, Rheinstetten, 
Germany) was used to simulate each metabolite with identical acquisition 
sequence and parameters that include identical radio frequency (RF)  
pulse profiles and timing that were used for the in-vivo acquisition. 
A conventional basis set was simply created by combining the simulated 
metabolite models. This conventional basis set was used for all in-vivo 
results. The water lineshape basis set was created individually for each 
acquisition by multiplying the corresponding water signal with the signal 
profile of each metabolite in the time domain. The water signal was 
normalized to its maximum intensity to exclude the effect of reference 
voltage variations. As the amplitude of the water signal was the same for 
all cases, this water lineshape basis set shows identical signal amplitude 
ratios in every case. The only difference was in terms of the lineshape. To 
create the water lineshape basis set, an additional water signal is required 
at the expense of prolonged scan time. However. the water signal is 
widely required as a routine protocol to have an absolute concentration 
quantification and an ECC. 
5.2.4  Data analysis
To verify the spectral quality under the three different B0 field 
homogeneity conditions, we measured the linewidth at the half maximum 
points from the water signal. The SNR of the in-vivo spectrum was also 
measured from the NAA peak and the white noise area  from 7 to 9 ppm 
for each case. 
Linewidths of metabolites and water were also compared in order to 
determine whether differences in T2 had a discernible effect on the line 
width. Full-width at half maximum (FWHM) of the water un-suppressed 
signal and clearly visible metabolite signals at 3.2 ppm (tCho: Cho + PCh + 
GPC), 3 ppm (tCr: Cr + PCr) and 2 ppm (tNAA: NAA + NAAG) for the three 
different shim conditions were measured with jMRUI software (ver. 6.0, 
http://www.jmrui.eu) (Stefan et al., 2009). 
LCModel (Version 6.3-1L, SW Provencher, Oakville, Canada) was used to 
quantify the absolute metabolic concentration and estimate 
quantification uncertainties, using the Cramer–Rao lower bound (CRLB), 
which is defined as the lowest possible standard deviation of all unbiased 
model parameter estimates obtained from the in-vivo data (Cavassila et 
al., 2000; Cavassila et al., 2001). For LCModel, the mean-squared  error   of  
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any  unbiased  estimator,   which  denotes  spectral parameters such as 
metabolite concentrations, linewidth and phase, is lower bounded by 
the square roots of the diagonal entries of the inverse of the Fisher 
information matrix, which essentially describes the correlations 
between spectral parameters (Zhang and Shen, 2014). As an index for 
the reliability of detection, decreased CRLB value is 
interpreted as denoting increased reliability for metabolite detection 
(Provencher, 1993). Prior to the spectral fitting, frequency referencing, 0th 
and 1st order phasing and ECC were performed by LCModel. 
Individually acquired spectra over coil elements and averages were 
aligned and combined by the 1st point signal weighting method 
(Brown, 2004). Spectral fitting was performed with two different basis 
sets, namely the conventional basis set and the water lineshape basis set 
with water scaling using individual water signals, which were acquired 
additionally in all cases. The LCModel parameter that controls the 
flexibility of the spline baseline (DKNTMN) was set to 0.1 as a default 
value. In order to explore the effect of the baseline spine function, the 
conventional basis set approach was also analyzed with DKNTMN set to 
values that gave a similar level of baseline fluctuation as that of the 
water lineshape basis set. For the lineshape, we did not modify the fitting 
parameter that controls linewidth (i.e. DEEXT2 and DESDT2). In 
addition, MM and lipid models were not considered in the baseline. 
However, since the lineshape and linewidth of the MM and lipid are not 
mathematically predictable, we used internally provided non-parametric 
spectral models for fitting MM and lipid signals. Therefore, we did not 
apply the water lineshape to the spectral models for MM and lipid. As 
LCModel recommends (Provencher, 2016), we also assumed that water 
concentrations of gray matter (GM), white matter (WM), and 
cerebrospinal fluid (CSF) are 43300, 35880, and 55556 mM, respectively. 
Quantified metabolic concentrations were expressed as mmol per kg wet 
weight. To exclude individual variations, metabolite concentrations were 
individually corrected by averaged concentrations over 10 subjects as 
estimated at the good shim condition. For this step, we assumed that the 
estimated metabolite concentrations from good shim data were close to 
the actual concentration. Metabolite concentrations and CRLB were 
compared between the conventional and water lineshape methods.
The typical acceptance value for the CRLB was under 30%, as 
recommended by other spectroscopy studies (Bank et al., 2015). 
Nevertheless, we only excluded CRLB values of 999%, which indicate the 
situation where metabolite was not detected. Previously, Kreis has 
warned that arbitrarily thresholded data may cause bias (Kreis, 2016). 
Therefore, we used a cut off as 998% as a previous study used (Soeiro-de-
Souza  et   al.,  2016)  in order  to include as many metabolites  as  possible
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and show CRLB changes between the conventional and water lineshape 
methods. An additional comparison was performed for the number of 
metabolites that was detected with CRLB below 30% and between 31 and 
998% by the two approaches. The statistical significance was determined 
by performing ANOVA analysis between three different linewidth groups, 
and two methods using SPSS (Ver. 22, IBM, NY). The null hypothesis was 
that there is no difference between the results obtained under different 
B0 homogeneity conditions.
5.3 Results
The water linewidths were 12.65 ± 2.23, 22.65 ± 2.32, and 36.16 ± 3.06(Hz) 
corresponding to the good, medium, and poor field homogeneity 
conditions, respectively. The overall range of the water linewidth was from 
9.98 to 39.52 Hz. The SNRs of the in-vivo spectra were 309.89 ± 77.30, 
235.68 ± 59.44, and 184.61 ± 28.20 corresponding to the good, medium, 
and poor field homogeneity conditions, respectively (see Figure 5.1).
Figure 5.1. Comparison of in-vivo spectra under three B0 field conditions from one representative 
subject. The mean linewidths measured from the water signal in the real mode were 12.65 ± 
2.23, 22.65 ± 2.32, and 36.16 ± 3.06 (Hz) corresponding to the good (red), medium (blue), and 
poor (yellow) field homogeneity conditions, respectively. Their corresponding mean SNRs were 
309.89 ± 77.30, 235.68 ± 59.44, and 184.61 ± 28.20, respectively.
Table 5.1 summarizes measured linewidths for the water and metabolite 
signals. For all shim conditions, we found comparable linewidths between 
the water and selected metabolite signals
Table 5.1 linewidth comparison for water and clearly visible metabolites: tCho, tCr and tNAA 
under three different shim condition, given as mean ± SD in Hz. Linewidths of the metabolites 
showed a good agreement with that of the water peak.
Good Medium Poor
Water 12.7 ± 2.2 22.7 ± 2.3 36.2 ± 3.1
tCho 13.7 ± 2.5 24.4 ± 2.5 37.7 ± 1.4
tCr 13.5 ± 2.1 26.0 ± 2.6 39.3 ± 1.7
tNAA 12.1 ± 1.1 24.4 ± 2.9 37.5 ± 0.7
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Figure 5.2 shows the steps for the spectral fitting model creation. The water 
lineshapes that acquired under each field homogeneity condition from one 
representative subject are compared, as shown in Figure 5.2A. As the B0 
field in the voxel becomes heterogeneous, the water lineshape changes 
from a Lorentzian form, and may become asymmetrical as shown for the 
broadest line. Figure 5.2B shows the NAA profile, which is calculated on 
the basis of spectral simulation using identical acquisition parameters to 
those used in vivo. Figure 5.2C shows a comparison of the modified basis 
sets under each field condition. The basis set was created by multiplying 
its corresponding water lineshape (see Figure 5.2A) with a simulated 
metabolite profile (see Figure 5.2B) in the time domain. The linewidth of 
the combined spectrum was dominated by that of the water. Therefore, 
the relatively narrow linewidth of the simulated spectrum did not affect 
the linewidth of the combined signal. 
Figure 5.2. (A) Comparison of water lineshapes under three different B0 field 
homogeneity conditions, namely good (red: linewidth of 11 Hz), medium (blue: 24 Hz), and 
poor (yellow: 39 Hz), from one representative subject. (B) Simulated NAA profile, which is 
widely used as a spectral fitting model. (C) Comparison of modified basis sets of NAA for the 
water lineshape fitting approach under each field condition. The water lineshape basis 
set is created by multiplying its corresponding (A) water signal with a (B) simulated 
metabolite profile in the time domain.
Figure 5.3 compares the average absolute concentration (A) and CRLB (B) 
as estimated using the conventional basis set, the conventional basis set 
with restricted baseline estimation and the water lineshape basis sets, for 
all metabolites quantified by LCModel fitting. When DKNTMN, which 
controls the baseline flatness, was set from 0.20 to 0.29, the baseline of 
the  conventional  basis set  showed  similar  fluctuation  levels to those of 
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the water lineshape basis set. Metabolites that were only detected by one 
method were excluded. In comparison with the conventional basis set, the 
water lineshape basis set tends to quantify the metabolite concentrations 
with lower variance for all three shimming groups. However, the water 
lineshape basis estimated metabolites with a greater fitting error for 
most metabolites. When the restricted baseline estimation is used, the 
conventional basis set approach estimates metabolite concentrations with 
a smaller variation and fitting error in comparison with the soft baseline 
approach for most metabolites.
Figure 5.3. Estimated average absolute concentration with 95% confidence intervals (shown 
as error bars) (A) and CRLB (B) under three different shimming conditions for the conventional 
basis set, conventional basis set with a restricted baseline, and the water lineshape basis set, 
for all metabolites quantified by LCModel fitting. In comparison with the conventional basis set, 
the water lineshape basis set tends to show lower concentration and higher CRLB values for 
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most metabolites. The dotted line of the figure 5.3A indicates zero mM. Note that metabolites 
detected by all three approaches were only compared.
Figure 5.4 shows the comparison of the summed metabolite 
concentrations (A) and average CRLB (B) over all metabolites for the three 
different approaches under the three different static field conditions: 
good (10 to 20 Hz), medium (20 to 30 Hz), and poor (30 to 40 Hz) that were 
used for data acquisition. In this comparison, we included all detected 
metabolites in order to compare overall changes of concentrations and 
CRLBs by two methods. Below a linewidth of 30 Hz, the two methods did 
not show a statistical difference for either index according to the p-value, 
which was greater than 0.05. In the poor shim group, the three approaches 
showed statistically significant differences for both the concentration and 
the CRLB. Even if summed metabolite concentrations are not significantly 
different between three approaches below a linewidth of 30 Hz (p value > 
0.05), the water lineshape approach showed a significantly lower variation 
than those of the conventional method and the conventional approach 
with a restricted baseline estimation for the concentration estimation. 
This effect was observable for all shimming groups. In addition, when the 
restricted baseline estimation was used, the conventional basis set 
method showed a smaller variation for both concentration and CRMB 
estimations compared to the smooth base line estimation. However, these 
improvements were inferior to those of the water lineshape basis set in 
terms of stability. This effect was observable for all shimming groups.
Figure 5.4. Comparisons of summed metabolite concentration (A) and median CRLB (B) over 
estimated metabolites by two three approaches between groups: good (10 to 20 Hz), medium 
(20 to 30 Hz), and poor (30 to 40 Hz) from the results shown in Figure 5.3. For linewidths of 10 
to 30 Hz, the two methods did not show a statistical difference for both indexes, with p-values 
greater than 0.05. However, for 30 to 40 Hz linewidth, the two three approaches showed 
statistically significant differences for both the concentration and CRLB.
A one-way analysis of variance (ANOVA) showed that average metabolite 
concentrations estimated using the conventional basis set were significantly 
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different between shim groups (F(2,30) = 5.184, p = 0.014). On the other 
hand, the water lineshape basis set estimated metabolites concentrations 
similarly over groups (F(2,30) = 1.484, p = 0.248). The averaged CRLBs 
over all metabolites that were estimated with the conventional basis set 
and the water lineshape model basis set increased as the static field 
became more heterogenous (see Figure 5.4B). However, the average 
CRLB obtained using the water lineshape basis set increased more steeply 
than those of the conventional basis set. ANOVA results showed that the 
estimated CRLB by the conventional basis set are not significantly 
different between shim groups (F(2,30) = 1.807, p = 0.187); whereas, that 
by the water basis set are significantly different (F(2,30) = 5.974, p = 
0.008).
Figure 5.5 shows the LCModel fitting results for an exemplary spectrum, 
with a linewidth of 39 Hz fitted using the conventional basis set, the 
conventional basis set with a restricted baseline estimation and the 
corresponding water lineshape basis set. This shows the fit for the most 
highly concentrated metabolites (NAA, PCh, Cr, Glu, and mI) and the 
baseline, for both quantification approaches. The conventional basis set 
showed a loose baseline constraint (Figure 5.5A) and when restricted 
baseline estimation was used, the conventional basis set showed a similar 
baseline fluctuation level to that of the water lineshape basis set (Figure 
5.5B). The water lineshape basis set showed a tighter baseline (Figure 
5.5C) in comparison with that of the conventional basis set. Different 
flexibility of the baseline constraint indicates that more degrees of 
freedom are required to fit with the conventional basis set. The 
fluctuating baseline generated from the conventional basis set made it 
possible to more closely fit the in-vivo lines than was possible for the 
water lineshape basis set. However, in this example the oscillating 
baseline causes unrealistic signal phasing (for example see PCh line (blue) 
in Figure 5.5A). In general, the estimates of metabolite concentration are 
higher for the conventional basis set.
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Figure 5.5. LCModel results for an exemplary spectrum, acquired with a linewidth of 39 Hz, 
fitted by (A) the conventional basis set, (B) the conventional basis set with restricted baseline 
estimation and (C) the water lineshape basis set. Fitted lines, baselines, residuals and the 
highest concentration metabolites (Glu, NAA, Cr, PCh, and mI) are shown. The different 
baselines correspond to loose (A), and tighter (B and C) baseline constraints which mean that 
more degrees of freedom are required to fit (A). The fluctuating baseline generated from the 
conventional basis set made it possible to more closely fit the in-vivo lines than was possible 
for the water lineshape basis set. However, in this example the oscillating baseline 
causes unrealistic signal phasing (for example see PCh line (blue) in Fig 5.5A). In general, the 
estimates of metabolite concentration are higher for the conventional basis set. The 
restricted baseline from the conventional basis set with constrained regularization 
still showed the phasing problem even if its level is decreased and there remained a 
higher level of the residual signal in comparison with other two approaches.
The average number of detected metabolites averaged over subjects 
for the two different b asis s ets, a re compared b etween t hree shimming 
groups in Figure 5.6. As shimming conditions get worse, both the number 
of detected metabolites decreased. The total number of metabolites 
detected was higher for the water lineshape approach for all shim groups, 
but the number with CRLB<30% was the same or less. When a restricted 
baseline estimation was used, the conventional basis set detected a 
decreased number of metabolites than with the other two approaches for 
linewidths of 20 to 30 Hz.
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Figure 5.6. Comparison of an average number of detected metabolites for the 
conventional basis set and the water lineshape basis set under three shimming conditions. 
For all shimming conditions, the water lineshape basis set detected more metabolites than 
the conventional basis set. However, the number of detected metabolites by the water 
lineshape basis set with CRLB < 30% was the same or less than that detected by the 
conventional basis set for all groups. When a restricted baseline estimation was used, the 
conventional basis set detected a decreased number of metabolites.
5.4  Discussion
This study demonstrated the effect of linewidth on estimates of metabolite 
concentration when using the realistic spectral model fitting. Lineshape 
modifications using the reference lineshapes from the water signal (Adalid 
et al., 2017; Slotboom et al., 1998) or the B0 map (Li et al., 2015) for the spectral 
fitting model have previously been reported. Similar to these previous 
studies, modified spectral models using the water lineshape in this study 
also improved the consistency and stability of spectral quantification for 
the B0 field inhomogeneity induced broad linewidth. For most metabolites, 
the water lineshape fitting method estimated more consistent metabolite 
concentration levels with smaller variations compared to the conventional 
fitting method, for the different field homogeneity conditions tested. 
However, the conventional fitting method had numerically lower values of 
the CRLB parameter.
A common limitation of spectral fitting methods is their lack of uniqueness 
(Belkic and Belkic, 2010). The objective of non-linear or linear least square 
fitting is to minimize the squared deviations from the mean (SDM) between 
the spectral models and the experimental spectrum without considering 
practical metabolite levels. Therefore, spectral fitting is always at risk of 
over- (detecting wrong signals) and under- (missing correct signals) fitting, 
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in the situation that in-vivo spectra do not have enough information for 
accurate quantification due to the inhomogeneous B0 field. This problem 
was also observed in our spectral fitting results. Even though there is no 
ground truth for the metabolite concentration level, if we assume that 
the spectral quantification result of the narrow linewidth spectrum, which 
was acquired under homogenous B0 field conditions, is closest to the 
ground truth regarding the metabolite levels, then the conventional basis 
over-estimated metabolite concentrations for the spectra obtained under 
the inhomogeneous B0 field conditions: medium and poor shim groups 
(see Figure 5.3A), whereas the water line shape basis gave similar 
estimates over the linewidth range examined. LCModel considers an 
additional line broadening term with a Voigt lineshape, which is the 
product of Lorentzian and Gaussian forms, to take into account the B0 
field inhomogeneity induce broad lineshape. More importantly, LCModel 
finds the best compromise between the broad in-vivo peak and model 
utilizing the smoothest peak profile (Marshall et al., 1997). Even if, these 
additional line broadening terms are considered by default in the 
LCModel, the conventional approach quantified metabolite 
concentrations with greater variations than did the water lineshape basis 
set. Figure 5.4A also substantiates the overestimation by the conventional 
approach as the corresponding concentration was significantly increased 
(p-value <0.005) for the poor shim results. 
The different degrees of freedom for spectral fitting appear to be a major 
reason for the difference between the two quantification approaches. As 
shown in Figure 5.5, the result from each method showed significantly 
different baseline flexibilities, which should be nearly flat in the ideal 
situation, because LCModel quantified MM and lipid signals using 
additional non-parametric models. The flexibility of the baseline 
determines the degrees of freedom of the baseline correction (Pradhan 
et al., 2016). LCModel adjusts the number of spline knots to change the 
spacing between knots that defines the level of freedom (Provencher, 
1993). The loosely restricted baseline of the conventional approach 
confirms that this method has a higher degree freedom for fitting than 
the water lineshape fitting that showed a tightly restricted baseline. This 
baseline fluctuation is a typical pattern that the LCModel analysis shows 
for a broad linewidth (Zhang and Shen, 2014). A highly flexible baseline 
due to the decreased spacing between knots made it possible to closely 
approach the total in-vivo line. However, it also allows a relatively high 
degree of freedom in terms of the spectral fitting. For the closely 
approached fitting line to the in-vivo line, LCModel provides improved the 
goodness of fit by decreasing the uncertainty of  fitting results.  However,
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improved precision does not necessarily mean that the metabolite was 
estimated correctly (Zhang and Shen, 2014). A fluctuating baseline may 
cause constrained phasing(see PCh line (blue) in Figure 5.5A) and also 
overestimate metabolites. The water lineshape basis set showed a flatter 
baseline, which is characteristic of a narrow linewidth, even though the 
linewidth of the in-vivo spectrum is broad (see Fig 5.5B). Even if T2 
relaxation times of the water and metabolites differ, the measured 
linewidths are similar for all shim conditions (see Table 5.1). In 
practice the lineshape is dominated by T2’ at ultrahigh field, and the T2 
contribution can be neglected. In comparison with the conventional 
basis set, the water lineshape basis set has a largely identical 
lineshape to the resultant spectra. Hence the line broadening part 
of the fitting algorithm will accommodate the lineshape thus limiting 
the degrees of freedom, and reducing the risk of over- or under-fitting. 
LCModel allows the modification of the baseline flexibility via a hidden 
menu. In this study, we tested the effect of modifying the control 
parameter with regard to the baseline flexibility. When the restricted 
baseline estimation was used, the baseline of the conventional basis 
set showed similar fluctuation levels to those of the water lineshape 
basis set. A constrained baseline for the conventional basis set 
showed an improved quantification performance in terms of accuracy 
and stability in comparison with the conventional method (see Figure 
5.3). However, the improvement was inferior to that of the water 
lineshape method (see Figure 5.4). Moreover, the arbitrarily constrained 
baseline failed to detect all metabolites detected by the other 
approaches when the B0 field was not homogeneous. We hence 
conclude that the water lineshape method is generally superior to 
the modified conventional method.
The LCModel estimates the goodness-of-fit in the output results 
according to the CRLB (Provencher, 1993). This index helps in assessing 
the precision of the spectral fitting method. It is widely accepted that a 
typical exclusion cut-off for this index is 30% (Dyke et al., 2017; 
Godlewska et al., 2017b; Považan et al., 2018). However, recently Kreis 
(Kreis, 2016) pointed out that the relative CRLB as a standard index has a 
limitation for use as an exclusion criterion, because low concentration 
metabolites necessarily show high CRLB values. For this reason, we 
included all detected metabolites for the analyses irrespective of CRLB. 
A relatively broadened and flattened spectral lineshape due to poor field 
inhomogeneity compared to that of the good-shim spectrum has 
insufficient information to detect a signal with high precision, resulting in 
relatively larger fitting error. This explanation is commonly applied 
regardless of fitting  methods. As shown in our results (see Figure 5.4B),
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the mean CRLB increases as the linewidth broadens for both fitting 
approaches. Nevertheless, the water lineshape approach showed a higher 
mean CRLB than the conventional approach. The poorer fitting quality for 
the water lineshape can be explained by two reasons: the water lineshape 
fitting shows higher CRLB for most metabolites (see Figure 5.3B) 
regardless of the field inhomogeneity. In addition, this approach detects 
additional metabolites with relatively high CRLB values (above 30%) that 
were not detected by the conventional fitting method (see Figure 5.6). 
The Increased CRLB value of the water lineshape method was mainly 
driven by these two factors. 
For the range of linewidths used in this study and under the 
assumption that an adequate water suppression can still be achieved, this 
study shows that the results obtained are considerably less sensitive to 
the linewidth for water lineshape fitting compared to the case of the 
conventional spectral fitting method. The spectral quantification 
procedure decomposes individual metabolites from the predefined in-
vivo signal as a post processing step. An error in the estimate of one 
metabolite can affect the estimates of others. Although this water 
lineshape approach is less precise compared to the conventional 
approach, considering the fundamental objective of proton 
spectroscopy, the water lineshape fitting approach is superior to the 
conventional approach in terms of accuracy. 
Our initial motivation for using the water lineshape method was to 
minimize differences between in-vivo and fitted model lineshapes so that 
LCModel quantification is less affected by the actual lineshape. In 
addition, we assumed that water lineshape is able to correct the 
lineshape better than mathematical algorithms since the lineshape 
modification by the B0 field inhomogeneity is not specified and 
increasing the number of correction steps may cause over- or under-
fitting. As the water lineshape method also relies on the lineshape 
correction algorithms that are inherent to LCModel (i.e., we did not 
turn off any lineshape and line broadening steps), the water lineshape 
method augments LCModel. The improvement in the stable metabolite 
concentration over the total metabolites confirms that the water 
lineshape approach in combination with LCModel fitting can be used for 
effective spectral estimation with enhanced accuracy in situations 
involving a wide linewidth.
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5.5 Supplementary material
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Figure 5.S1 Examples of the LCModel result that were fitted by (A) the conventional basis set, 
(B) the conventional basis set with restricted baseline estimation and (C) the water lineshape
basis set. Fitted lines, baselines, residuals and the highest concentration metabolites (Glu, NAA, 
Cr, PCh, and mI) are shown. For the restricted baseline estimation, the used value of DKMTMN
is shown on each Figure (B).
Table 5.S1 LCModel control parameters that were used for (A) the conventional basis set, (B) 
the conventional basis set with restricted baseline estimation and (C) the water lineshape basis 
set. Note that default values provided by LCModel were used for the unmentioned parameters
 Parameter Description (Provencher, 2016)
(A) 
Conventional 
basis set
(B) 
Conventional 
basis set with 
restricted 
baseline 
estimation 
(C)
 Water 
lineshape
 basis set
attmet the attenuation of the singlet 1.0 (Default)
wconc NMR-visible water concentration 35880 (Default)
atth2o the attenuation of water when TE=38 0.62
namrel basis met for relative concentration ‘NAA’
ppmst left edge of the window 4.2
ppmend right edge of the window 0.6
neach number of metabolites for individual plots 99
echot echo time 38.00
dows water scaling T
doecc eddy current correction T
nunfil data points 1024
deltat dwell time 4.000e-04
hzpppm field strength 2.9715e+02
DKNTMN node spacing of the spline function 0.1 (Default) 0.20 ~ 0.29 0.1 (Default)
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Abstract
Magnetic susceptibility differences between grey matter (GM) and white matter (WM) 
can potentially affect lineshapes and chemical shifts in single-voxel spectroscopy. This 
study aimed to investigate the consequences and potential utility of these effects. 
Spectroscopy voxels were segmented into GM, WM, and cerebrospinal fluid 
based on T1-weighted images. GM and WM lineshapes were computed using 
multi-echo gradient-echo images to measure the frequency distribution. Twenty 7 
Tesla single voxel spectra with corresponding T1-weighted images were acquired 
from the frontal and parietal lobes from five healthy human volunteers. Consistent 
frequency shifts (mean [± SD] 4.9 ± 2.0 Hz) and linewidth differences (2.4 ± 1.5 Hz) 
between the two tissue types were observed. Directly visible metabolites (creatine, 
choline, and myo-inositol) exhibited frequency shifts and linewidth differences 
that were consistent with a linear-weighted summation of their expected GM and 
WM distribution ratios. The magnetic susceptibility difference between GM and WM 
had a detectable effect on single-voxel proton spectra, which results in both 
frequency shifts and lineshape broadening. This effect can be used to estimate the 
relative metabolic distribution in the GM and WM for directly observable 
metabolites. Fractional distributions estimated with this method demonstrated 
good agreement with literature values for the selected metabolites.
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6.1  Introduction
Magnetic resonance spectroscopy (MRS) is a widely used, non-invasive 
technique for the measurement of metabolite levels in the human brain. 
Emerging ultra-high field (≥ 7 Tesla [T]) applications can potentially 
deliver great benefits in MRS studies, with expected advantages including 
improved spectral resolution resulting from the increased chemical shift 
caused by the stronger static magnetic field; a simplified J-coupled spectral 
pattern; and a higher signal-to-noise ratio (Uğurbil et al., 2003). Ultra-high 
field MRS has been reported to show improved reliability for quantitative 
assessments of metabolites that are present at low concentrations or 
exhibit complex signal patterns (Tkáč et al., 2004). These advantages result 
in an increased number of detectable metabolites in the human brain (Tkáč 
et al., 2004). For these reasons, MRS is potentially more important at higher 
static field strengths.
However, one potential confound has, hitherto, received little attention 
from the spectroscopy community. Recent imaging studies have reported 
a potential 5–10 Hz frequency shift between grey matter (GM) and white 
matter (WM). Several potential causes of this phenomenon have been 
proposed: deoxyhemoglobin in the blood combined with different vascular 
densities in the GM and WM (Lee et al., 2010a; Marques et al., 2009; 
Reichenbach et al., 1997); different concentrations of tissue components, 
such as myelin (Liu et al., 2011; Ogg et al., 1999), iron (Fukunaga et al., 2010; 
Haacke et al., 2005; Yao et al., 2009), ferritin (Duyn et al., 2007), and calcium 
(Wu et al., 2009); geometry and orientation of tissue structures to the B0 
field (He and Yablonskiy, 2009; Lee et al., 2010b); and, finally, the chemical 
exchange effect (Luo et al., 2010; Shmueli et al., 2011; Zhong et al., 2008). 
The magnetic susceptibility difference between GM and WM will generally 
result in a gradient of the static field at the boundary between the two tissue 
components, and a frequency shift. This may result in a different lineshape 
for metabolites in each tissue and, more importantly, a different frequency 
for each tissue type in spectroscopy. The recorded total signal will be the 
weighted sum of the signals from each tissue. The potential consequences 
of this effect are lineshape and frequency shifts for metabolites that are 
dependent on the distribution of the two tissue types. 
A recent study by Maudsley et al. (Maudsley et al., 2017) reported a 
difference in metabolite frequencies that was dependent on the relative 
volume fractions of GM and WM. Using MRS imaging (MRSI) at 3 T, the 
authors found a frequency difference of approximately 0.4 Hz between 
GM and WM from the water frequency for N-acetylaspartate (NAA), 0.4 
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Hz for creatine (Cr), and 0.6 Hz for choline (Cho). In addition, these shifts 
exhibited a linear dependence on the relative GM and WM concentrations. 
This finding reflects a frequency shift for different environments. Prior 
to this study, Chadzynski, et al. (Chadzynski et al., 2011) also evaluated 
frequency differences for tissue-dependent variation using MRSI at 3T. 
The frequency differences from water to each metabolite were slightly 
different between GM and WM, with differences of approximately 1.2 Hz 
for total Cho (tCho), 0.9 Hz for total Cr (tCr), and 1.8 Hz for NAA. Based 
on these previous studies, the current study attempts to directly measure 
magnetic susceptibility-dependent frequency shifts in GM and WM by 
combining single-voxel proton spectroscopy at 7 T with frequency mapping 
using multi-echo gradient-echo (GRE) images that were acquired at the 
identical spectroscopy voxel position. By measuring at a number of different 
voxel positions, we were able to assess the way in which susceptibility 
differences translate into lineshape and frequency variations in practice. 
This technique also enabled us to compute GM and WM lineshapes and 
frequency distributions. For spectral lines that can be manually assigned, 
we examined whether the relative distribution of a metabolite between 
GM and WM could be estimated from the subtle differences in frequency.
6.2 Materials and Methods
6.2.1  General strategy
Because single-voxel spectroscopy (SVS) has no spatial discrimination 
within the voxel of interest (VOI), GM and WM signals cannot be directly 
distinguished from an SVS signal. Therefore, previous studies (Bank et 
al., 2015; Hofmann et al., 2002) acquired GM and WM signals separately 
from voxels where one tissue type tends to dominate. In the present study, 
however, a multi-echo GRE imaging approach was used that was based on 
the concept that an SVS signal can be considered to be an aggregation 
of signals from multiple mini-voxels inside a measurement volume. Each 
single mini-voxel signal offset can be estimated by the phase evolution of 
the multi-echo GRE images. By sorting mini-voxels into corresponding GM 
and WM components, we can obtain reference GM and WM signals, and 
measure the magnetic susceptibility-induced frequency shift between the 
GM and WM in SVS for a range of voxels. 
Each mini-voxel signal has an inherent resonance frequency that can be 
determined by the local B0 field strength; an amplitude determined by 
the spin density, flip angle, and T1-relaxation; and a lineshape determined 
by the form of the T2* relaxation envelope. Each mini-voxel S(t) can be 
expressed as: 
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             (6.1)
in which ω is an angular frequency and A is the amplitude of the mini-
voxel signal. By summing all mini-voxel signals, it is possible to obtain an 
estimate of the total single-voxel signal. This will, however, not be identical 
to that obtained in SVS because of differences in the T1-weighting of the 
acquisitions caused by different repetition times (TRs) between the two 
measurements. For the purposes of this study, however, it was adequate to 
obtain an estimate of the lineshape and frequency offset for GM and WM 
separately. Line broadening effects due to respiration were not considered 
explicitly, but it was assumed that these factors would not be systematically 
different for both tissue types in the voxel of interest.
6.2.2  Data acquisition
Both magnetic resonance imaging (MRI) and MRS data were acquired 
from 5 healthy volunteers (1 male, 4 female; mean age, 31.8 ± 2.64 
years) using a 7 T (f0 = 297.21 MHz) whole-body system (Magnetom, 
Siemens AG, Erlangen, Germany) equipped with a 32-channel phased-
array head coil (NOVA Medical, MA). All examinations were performed 
in accordance with local ethics committee regulations. First, T1-
weighted images were acquired as an anatomical reference. A 
three-dimensional MPRAGE (Magnetization Prepared Rapid 
Acquisition Gradient Echo) sequence (Mugler and Brookeman, 1990) 
was used with the following parameters: matrix size = 256 * 256 * 256 
resolution = 1 mm3 isotropic voxel, TR = 2300 ms, echo time (TE) = 1.35 
ms, inversion time (TI) = 1100 ms, and flip angle (FA) = 6°.
Four spectroscopy data sets were collected for different brain regions 
(left frontal lobe, right frontal lobe, left parietal lobe, and right parietal 
lobe) in each subject. Spectroscopy voxel positions were adjusted to 
minimize cerebrospinal fluid (CSF) contamination. To directly detect a 
frequency shift effect from in-vivo spectra, one primarily GM voxel at the 
occipital cortex and one primarily WM voxel at the dorsolateral prefrontal 
cortex were also selected. B0 field shimming was performed using 
FASTESTMAP (Gruetter and Tkáč, 2000). This was repeated a maximum 
of 5 times to obtain the best possible B0 field homogeneity condition. 
The semi-LASER (Semi-Localized by Adiabatic SElective Refocusing) 
sequence (Scheenen et al., 2008a; Scheenen et al., 2008b) was used to 
obtain spectroscopic data from an 8 cm3 isotropic voxel, with TE = 38 ms, 
TR = 4500 ms, and 64 signal averages, using WET (water suppression 
enhanced through T1 effects) water suppression (Ogg et al., 1994). The 
spectral acquisition bandwidth was 3500 Hz, which is approximately 12 
parts per million (ppm) at 7 T.
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Water-unsuppressed spectra were also collected from all spectroscopic 
voxels that were examined.
GRE imaging with four different TEs followed every spectroscopic scan 
to obtain a frequency offset distribution at the same location as the 
spectroscopic voxel with the following parameters: 1 mm3 isotropic voxel; 
3D imaging matrix = 256 * 256 * 20; TR = 60 ms; TEs = 10, 14.24, 18.48, and 
22.72 ms; and FA = 20°. To have identical B0 field homogeneity conditions, 
shimming steps were not applied before acquiring the GRE imaging scans. 
Identical image resolution and geometry coordinates to the T1 weighted 
image were used to accurately map mini-voxels on the GM and WM 
locations. 
6.2.3  Data processing
A multi-TE B0 mapping method was used to obtain the frequency 
distribution within each spectroscopy voxel. The frequency offset f of 
each sub-voxel was estimated as follows: 
             (6.2)
             (6.3)
in which, θ denotes the phase angle at a given TE that is obtained from the 
phase image. Δθ is the phase evolution per increment in TE (ΔTE, spaced by 
4.24 ms). Phase changes were calculated by linear regression. A reference 
lineshape for the spectroscopy voxel was reconstructed by combining 
individual mini-voxel components of the frequency offset map on the 
assumption that the reconstructed reference signal is identical to that of 
the water signal. Segmentation of GM, WM, and CSF maps was performed 
using the probabilistic segmentation algorithm of SPM12 (Wellcome Trust 
Centre for Neuroimaging, University College London, UK) (Ashburner and 
Friston, 2005) on the T1-weighted images, which were used as an anatomical 
reference for the spectroscopic scan. GM and WM signals were estimated 
by recombining frequency components of the frequency offset map at 
the equivalent voxel positions that corresponded to GM and WM. CSF 
components were excluded because they were not expected to contain 
significant quantities of metabolites (Joanna et al., 1993). The size of each 
mini-voxel is defined by the imaging resolution that is a 1 µl isotropic voxel 
for both T1-weighted and multi-echo images. Therefore, the spectroscopy 
voxel of 8 ml contains eight thousand mini voxels. GM and WM volumes 
were calculated by summing corresponding mini-voxels in the GM and 
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WM masks. Since the reconstructed lineshape showed a somewhat jagged 
outline due to the finite number of mini-voxels measured, we applied a 1.5 
Hz Lorentzian apodisation. The same level of line broadening to the water 
lineshape was also applied to compare the reconstructed lineshape and 
water lineshape under the same conditions. Custom MATLAB (ver. 2016b, 
Natick, MA) scripts were used for all processing steps.
6.2.4  Data analysis 
To compare the spectral similarity between a water lineshape from acquired 
spectroscopy data and a reconstructed reference lineshape from images, 
cross-correlation analysis was performed. 
Widely used spectral fitting packages, such as LCModel (Provencher, 2001), 
jMRUI (Stefan et al., 2009), and MIDAS (Maudsley et al., 2006) include various 
optimization algorithms (i.e. VARPRO for LCModel; Levenberg–Marquardt 
for jMRUI and MIDAS) to correct potential B0 instability or magnetic 
susceptibility-induced frequency shifts. Because these optimization steps 
are included by default, a quantification method using spectral fitting was 
not applied in this study to identify individual metabolite frequencies. 
Instead, peak position linewidths were directly measured after enhancing 
the spectral resolution to 1 ppb (parts per billion) by zero filling and a 
manual zero-order phase correction. The highest point of the peak and 
distance between two half-maximum points were considered to be the 
peak location and linewidth, respectively given as mean ± SD in Hz. The 
NAA location was then set as a reference position instead of the water 
peak to avoid any brain temperature-induced frequency shift because the 
temperature distribution in the human brain is not homogeneous (Maudsley 
et al., 2016). Under the assumption that NAA has a concentration of 52.4% 
in GM and 47.6% in WM (Gasparovic et al., 2009; Kreis, 1997; Maudsley et 
al., 2009; Pouwels and Frahm, 1998; Tal et al., 2012), the position of the 
NAA resonance was corrected by this fractional value based on the total 
frequency shift between the GM and WM of the reconstructed signal. 
Three clearly observable metabolites at 4.05 ppm, 3.61 ppm, 3.20 ppm, and 
3.01 ppm, designated as myo-inositol2 (MI2), MI1, Cho, and Cr, respectively, 
were selected to measure peak locations and linewidths. The linewidth of 
MI was not measured because the half-maximum height was hidden by 
adjacent peaks. Table 6.1 summarizes concentrations of not only these 
representative metabolites but also typically detectable brain metabolites. 
NAA was of course not examined because it was used as a reference value. 
All preprocessing and measurement steps were performed using the jMRUI 
software package (ver. 6.0, The MRUI Project) (Stefan et al., 2009). 
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Table 6.1. Literature concentrations and fractional distributions of typically detectable 
metabolites in the grey matter (GM) and white matter (WM) of the human brain, obtained by 
in-vivo proton spectroscopy studies.
Metabolite 
(Abbreviation)
Concentration
(mmol/kg, wet weight*
mmol/kg, water**
a.u.***)
Fraction value (%)
Brain Region Technique Reference
GM WM GM WM
Choline (Cho)
1.35±1.5* 1.58±1.1 46.08 53.92 Multiple Multiple (Kreis, 1997)
679±12*** 858±15 44.18 55.82 Frontal MRSI (Maudsley et al., 2009)
1.2±0.2* 1.4±0.2 46.15 53.85 Total MRSI (Tal et al., 2012)
Phosphocholine 
(PCh) 0.2±0.2* 0.0±0.1 100 0
Centrumsemiovale 
& 
Occipital
SVS (Hofmann et al., 2002)
Glycerophosphocholine 
(GPC) 1.3±0.3* 1.9±0.3 40.62 59.38
Centrumsemiovale 
& 
Occipital
SVS (Hofmann et al., 2002)
PCh +GPC 1.3±0.1* 1.9±0.3* 40.62 59.38 Cingulate & Corona Radiata SVS (Bank et al., 2015)
Creatine (Cr)
8.36±0.7* 6.27±1.0 57.14 42.86 Multiple Multiple (Kreis, 1997)
3145±42*** 2936±59 51.72 48.28 Frontal MRSI (Maudsley et al., 2009)
6.7±0.6* 4.8±0.4 58.26 41.74 Total MRSI (Tal et al., 2012)
17.40±1.51** 9.05±0.93 65.81 34.09 Multiple MRSI (Gasparovic et al., 2009)
Phosphocreatine 
(PCr) 8.1±0.5* 7.8±0.5 50.94 49.06
Cingulate & 
Corona Radiata SVS (Bank et al., 2015)
Myo-inositol (MI)
5.92±1.6* 4.85±2.1 54.97 45.03 Multiple Multiple (Kreis, 1997)
5.4±0.7* 4.6±0.7 54.00 46.00 Total MRSI (Tal et al., 2012)
N-Acetylaspartate 
(NAA)
10.32±0.9* 9.86 + 0.7 51.14 48.86 Multiple Multiple (Kreis, 1997)
8.4±0.9** 8.0±0.9 51.22 48.78 Multiple SVS (Pouwels and Frahm, 1998)
4523±59*** 4857±67 48.22 51.78 Frontal MRSI (Maudsley et al., 2009)
8.4±0.7* 7.6±0.5 52.50 47.50 Multiple MRSI (Tal et al., 2012)
20.96±0.84** 17.22±1.61 54.86 45.14 Multiple MRSI (Gasparovic et al., 2009)
N-Acetylaspartylglutamic 
acid (NAAG) 0.9±0.5** 2.3±0.4 28.13 81.87 Multiple SVS
(Pouwels and Frahm, 
1998)
In order to investigate the contribution of each metabolite to the observed 
peak in the GM and WM, absolute quantification of each metabolite was 
performed with water scaling using LCModel (Ver. 6.3-1L, S-Provencher, ON, 
Canada) (Provencher, 1993, 2001) for the additionally acquired primarily 
GM and WM voxels.
Measured peak positions were used to examine whether we could determine 
the relative distribution between the GM and WM. Under the assumption 
that the metabolic frequency shift is given by the linear weighted sum of 
the metabolic distribution ratios in the GM and WM, relative concentrations 
in the GM and WM could then be calculated on the basis that: 
(6.4)
in which ΔS is the observed shift in resonance frequency from the 
theoretical value in Hz, and  are the fractional concentrations 
in the GM and WM, and  are tissue volume fractions in the GM 
and WM. The potential effect of T2 relaxation time variation over individual 
metabolites was also considered. and  are the fractional T2 
correction factor in the GM and WM.
Estimated fractional distributions, according to Equation 4, were compared 
with values reported in the literature. As the identifiable signals that 
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we measured are in fact compounds of multiple resonances located at 
the same chemical shift (Govindaraju et al., 2000), fractional distribution 
values from the literature were used to calculate the weighted average 
of the metabolites using the values from Table 6.1. It is important to 
note that metabolic concentrations reported in arbitrary units were 
excluded.  The NMRSIM module of the Topspin package (ver. 3.6, Bruker 
Biospin, Rheinstetten, Germany) was used to simulate MI, glycine (Gly), 
Cho, phosphocholine (PCh), glycerophosphocholine (GPC), Cr, and 
phosphocreatine (PCr), with identical acquisition parameters to those used 
in-vivo.
6.3  Results
Figure 6.1A shows a T1-weighted image of the 8 mL spectroscopy voxel 
from one representative subject in the axial plane within the spectroscopy 
voxel. The corresponding GM (blue), WM (green) and CSF(orange) masks, 
segmented on the basis of T1-weighted images, are shown in Figure 6.1B. A 
frequency offset distribution, calculated by multi-echo GRE images inside 
the spectroscopy voxel of Figure 6.1A using a color scale with a range of 40 
Hz, is shown in Figure 6.1C.
Figure 6.1. (A) A T1-weighted image of the voxels of interest from one representative subject. 
(B) corresponding grey matter (GM, blue), white matter (WM, green), and cerebrospinal fluid
(orange) image segmentation mask. to identify mini-voxel coordinates corresponding to GM 
and WM. Frequency offset map (C) calculated from multi-echo gradient-echo images inside the 
8 mL spectroscopy voxel of (A). The frequency offset range is -20 Hz to 20 Hz.
Examples of each processing step from a single subject are shown in 
Figure 6.2. First, a water signal is shown, which was acquired from an in-
vivo spectroscopy scan in which the water suppression was turned off 
(A), and a reconstructed reference signal (B) from the multi-echo imaging 
data. The average water linewidth in real mode was 15.7 ± 1.4 Hz for the 
water lineshape from the in-vivo scan. The average correlation coefficient 
between the water lineshape and reconstructed reference lineshape was 
0.988 ± 0.007, over all voxels. Figure 6.2C shows a signal separation result 
that was generated by the corresponding frequency offset map (Figure 
6.1B) and segmentation masks (Figure 6.1C). Blue and orange represent the 
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GM and WM, respectively. Figure 6.2D shows separate GM (blue) and WM 
(red) signals, as well as the water signal as a reference (yellow), normalized 
to the same peak value.
Figure 6.2. Example of an acquired spectroscopy water signal (A), shown as a reference. (B) 
Histogram for the frequency offset distribution (grey) of 8000 mini-voxels. The histogram 
outline (red) reflects the sum of the of the mini-voxel signals. As we applied line broadening 
of 1.5 Hz to generate a smooth lineshape from the histogram, the amplitude of the fitted line 
(red) is somewhat lower than actual amplitude (grey). (C) Classified mini-voxel components of 
the grey matter (GM, blue) and white matter (WM, red) by segmentation masks from a single 
subject, and (D) separated GM (blue) and WM (red) lineshapes after applying a smoothing step 
with a line-broadening factor of 1.5 Hz. Water (yellow) is shown as a reference lineshape. The 
inset to figure (D) illustrates an expanded view of frequency differences between the GM and 
WM lineshapes. Note that signal intensities are normalized by their maximum values to obtain 
an intuitive comparison.
The frequency shift relative to the NAA reference signal was found, and 
the linewidth difference between the separated GM and WM signals for 
all voxels that were examined calculated: these results are summarized in 
Table 6.2. The average frequency shift between the GM and WM was 4.9 
Hz. The averaged GM signal was shifted 2.5 Hz in the negative frequency 
direction compared with the water signal, while the averaged WM signal 
was shifted 2.4 Hz in the positive direction. All subjects showed identical 
shift directions for the GM and WM signals, indicating that the shift was 
caused by intrinsic susceptibility differences, and not by differences in the 
shim. 
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Table 6.2. Observed frequency shift and linewidth differences between separated grey matter 
(GM) and white matter (WM) signals (see Figure 6.2D) from the reconstructed signal. Note that 
A center frequency of the reconstructed reference frequency was assumed to be 0 parts per 
million (ppm) 
Observed frequency shift Observed linewidth
(Hz) (ppb) (Hz)
GM -2.5 ± 1.3 -8.4 ±4.4 14.8 ± 2.1
Difference between the GM and WM 4.9 ± 2.0 16.5 ±6.7 2.4 ± 1.5
WM 2.4 ± 1.3 8.1 ± 4.4 14.0 ± 2.1
Average linewidths of the GM and WM signals after separation were 14.8 ± 
2.1 Hz and 14.0 ± 2.1 Hz, respectively. The difference between the averaged 
GM and averaged WM linewidths by 
was approximately 0.8 Hz. However, because the linewidth of one specific 
tissue type was not always wider than that of the other, individually 
compared linewidth differences between the two tissue types by (
) were found to be > 0.8 Hz. The 
mean individual linewidth difference between the GM and WM was 2.4 ± 
1.5 Hz. Considering that the averaged water linewidth was 15.7 Hz, the 
linewidths of separated GM and WM signals were both somewhat 
narrower than that of the water signal. 
Figure 6.3 shows the simulation results of metabolites that that 
constitute the signals measured at 4.05 ppm, 3.61 ppm, 3.20 ppm, and 
3.01 ppm. (Figure 6.3A) Selected MI peaks at 3.6144 ppm and 4.0538 ppm 
were uncontaminated by Gly. Cr: PCr and PCh: GPC coincide perfectly at 
3.01 ppm and 3.20 ppm, respectively (see Figure 6.3B and 6.3C). 
Therefore, we refer to the 3.01 ppm peak as tCr, and the 3.20 ppm peak 
as tCho. A significant contribution of Cho to the 3.20 ppm signal would 
have broadened the line by approximately 4.5 Hz, which was not observed 
in practice. Hence, the calculated relative distributions for these 
resonances between WM and GM on the basis of the literature are: MI 
(GM 54.49%, WM 45.51%) (Kreis, 1997; Tal et al., 2012), tCho (PCh + GPC: 
GM 40.62%, WM 59.38%) (Bank et al., 2015);, and tCr (Cr + PCr: GM 
58.71%, WM 41.29%) (Bank et al., 2015; Gasparovic et al., 2009; Kreis, 
1997; Maudsley et al., 2009; Tal et al., 2012). 
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Figure 6.3. Simulated signals of (A) MI (blue) and Glycine (Gly, red), (B) choline (Cho, red), 
phosphocholine (PCh, blue), glycerophosphocholine (GPC, green) and (C) creatine (Cr, red) and 
phosphocreatine (PCr, blue). Spectral overlap of myo-inositol (MI) and Gly was not seen at the 
two chemical shifts where MIs were measured (4.05 and 3.6ppm, A). Because PCh and GPC have 
the same resonance at 3.2 ppm, and PCr and Cr have the same resonance at 3 ppm, the 3.2 ppm 
peak was referred to as total Cho (tCho), and the 3-ppm peak as total Cr (tCr). The fractional 
distribution of tCho and tCr in the grey matter and white matter were calculated by using 
weighted averages of the metabolite values and the corresponding absolute concentrations 
in millimole (mM) from Table 6.1. Note that all simulated signals were normalized to the same 
peak value for an accurate comparison. 
Two spectra from the GM and WM voxels of one representative subject 
are compared in Figure 6.4A. The GM voxel had 82.9% GM and 17.1% WM, 
and the WM voxel had 29.9 % GM and 70.1 % WM. After NAA referencing, 
a clear frequency shift was observed for tCr, tCho, and MI. By contrast, 
two in-vivo spectra acquired from voxels that included similar tissue 
volume contents (74.1 %: 24.2 % and 76.0 %: 21.9 % for the GM: WM, 
respectively) did not show a noticeable frequency difference for the 
selected metabolites (Figure 6.3B). Values for the peak positions shown in 
Figure 6.4A are given in Table 6.3A, and absolute concentrations of the 
metabolites contributing to the measured peaks are also summarized in 
Table 6.3B. Most metabolites except GABA, GPC and Gly showed similar 
concentrations between the GM and WM voxel. 
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Figure 6.4. Peak position comparison of two spectra from a single subject that were acquired 
where the grey matter (GM) and white matter (WM) volumes differ markedly (A) 82.9%: 
17.1% (GM: WM, red) and 29.9%: 70.1% (GM: WM, blue) and are near equal (B) 74.1%: 24.2% 
(GM: WM, red) and 76.0%: 21.9% (GM: WM, blue). Spectra from unequally distributed GM and 
WM voxels (A) demonstrated greater frequency differences compared with those from 
relatively equally distributed voxels (B). Peak positions were measured after N-
acetylaspartate (NAA). This finding indicates that the measurable frequency shifts are caused 
by differences in voxel composition.
Table 6.3. Representative frequency differences (A) between metabolites and NAA based 
on data shown in Figure 6.4A and estimated metabolite concentrations with CRLB (B) by 
LCModel fitting for the GM and WM voxels.
(A) Theoretical difference (ppm)
(Govindaraju et al., 2000)
Observed difference (ppm)
GM voxel WM voxel
tCr- NAA 1.019 1.017 1.020
tCho - NAA 1.200 1.200 1.205
MI1 - NAA 1.606 1.603 1.610
MI2 - NAA 2.046 2.042 2.050
(B) GM voxel WM voxel
Conc (mM) CRLB (%) /NAA Conc (mM) CRLB (%) /NAA
2 ppm
NAA 8.041 1 1 7.586 2 1
NAAG 0.674 14 0.084 0.924 10 0.122
3 ppm
Cr 1.549 12 0.193 1.297 18 0.171
PCr 4.946 4 0.615 5.027 5 0.663
GSH 1.777 7 0.221 1.718 7 0.214
GABA 1.123 38 0.14 0.277 157 0.037
3.2 ppm
Cho 0 999 0 0 999 0
PCh 0 999 0 0 999 0
GPC 0.68 5 0.085 1.347 4 0.178
3.6 / 4 ppm
MI 4.405 5 0.548 5.162 5 0.68
Gly 0.574 25 0.071 0.032 540 0.004
Grey matter (GM) voxel contained 82.9%: white matter (WM) voxel contained 27.1%; WM voxel had 29.9%: 
70.1% (GM: WM). tCho: total choline; tCr total creatine; MI: myo-inositol; NAA: N-acetylaspartate; ppm: 
parts per million 
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Figure 6.5 shows an averaged spectrum in real mode across all 20 in-vivo 
datasets that were acquired from 4 regions in 5 subjects. The measured 
metabolite positions and linewidths for MI, tCho, and tCr are also 
summarized in Table 6.4. NAA was used as a reference peak at 2.0076 
under the assumption that NAA is distributed in the ratio of 52.4:47.6 for 
the GM:  WM. For the three other metabolites considered, we measured 
chemical shifts of tCr 3.0256 ppm (literature value, 3.0270 ppm), tCho 
3.2096 ppm (3.2080 ppm), MI1 3.6129 ppm (3.6144 ppm), and MI2 4.0521 
ppm (4.0538 ppm) relative to NAA 2.0076 ppm (2.0080 ppm), which has a 
frequency independent of brain temperature (Govindaraju et al., 2000).
Figure 6.5. An averaged spectrum across all 20 in-vivo datasets that were acquired from 
4 regions in 5 subjects N-acetyl aspartate (NAA) showing the peak locations of 4 
metabolites (two myo-inositols [MI], total choline [tCho], and total creatine [tCr]), 
which are clearly visible. The measured locations of MI (literature values, 3.6144 parts per 
million [PPM] and 4.0538 ppm), tCho (3.2080 ppm), and tCr (3.0270 ppm) were at 
3.613 ± 0.02, 4.0521 ± 0.02, 3.2096 ± 0.01, and 3.0256 ± 0.01 ppm, respectively, for in-
vivo measurements. Note that NAA was at 2.0076 ppm as a reference peak on the 
assumption that NAA is distributed at an approximate ratio of 51.6:48.4 (grey matter: white 
matter). 
Previously reported metabolic T2 relaxation times at 7 T (shown in 
parentheses) are as follows: tCho (GM 197 ms, WM 130 ms); tCr (GM 127 
ms, WM 109 ms); and MI (GM 160 ms, 100 ms) at 7T (An et al., 2017; 
Marjańska et al., 2012). Individually calculated fractional distributions 
between the GM and WM using Equation 4 with its corresponding 
parameters are summarized in Table 6.4. Estimated mean fractional 
distribution ratios for the selected metabolites showed good agreement 
with the literature values that were collated from multiple literature 
values shown in Table 6.1. 
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Table 6.4. Measured frequency shifts and linewidths of metabolites in the in-vivo spectra after 
referencing by NAA (see Figure 6.3) 
Chemical Shift (ppm)
(Govindaraju et al., 2000)
Frequency 
shift (Hz)
a - b
Average 
Linewidth 
(Hz)
Averaged 
fractional 
distribution from 
Table.6.1 (%)
Estimated fractional
distributions (%)
Theoreticala Observedb GM WM GM WM
tCr 3.0270 3.026 ± 0.001 -0.4 ± 0.3 15.432 ± 2.341 58.71 41.29 62.27 ± 8.01 37.73 ± 8.01
tCho 3.2080 3.210 ± 0.001 0.4 ± 0.3 14.343 ± 1.465 40.62 59.38 42.48 ± 5.25 57.52± 5.25
MI1 3.6144 3.613 ± 0.002 -0.4 ± 0.3 - 54.49 45.51 61.75 ± 6.30 38.25 ± 6.30
MI2 4.0538 4.052 ± 0.001 -0.5 ± 0.3 - 54.49 45.51 60.24 ± 7.13 39.76± 7.13
The calculated distribution between grey matter (GM) and white matter (WM) on the basis of 
metabolic frequency shifts obtained using Equation 4, which considers segmented tissue volume 
fractions. Note that the theoretical distribution of GM and WM of each metabolite is calculated by 
weighted averaging literature values by its corresponding concentration in Table 6.1. The linewidth of 
MI was not measured because the half-maximum height was hidden by adjacent peaks. tCho: total 
choline; tCr total creatine; NAA: N-acetylaspartate; ppm: parts per million 
The scatter plots shown in Figure 6.6A illustrate the estimated frequency 
differences from imaging between the GM and WM over B0 field  
inhomogeneity. Estimated frequency shifts from imaging varied directly 
with B0 field inhomogeneity. Figure 6.6B shows the proportion of each 
tissue type contributes to the whole frequency difference for each 
subject. 
Figure 6.6. Scatter plot (A) of estimated frequency differences from imaging between grey 
matter (GM) and white matter (WM) as a function of water linewidth. The weak dependency of 
the two parameters indicates that the shim is not the main factor in determining the frequency 
difference. Bar plot (B) shows the frequency offsets for GM and WM for each voxel measured. 
The consistent difference in sign for the frequency shift measured indicates that it is caused by 
an intrinsic property of the tissue. 
Individually calculated fractional GM distributions against the measured 
frequency difference between the reconstructed GM and WM signals are 
illustrated in the scatter graph with linear regression (solid line) and 95% 
confidential interval (dotted line) lines for MI (Figure 6.7A), tCho (Figure 
6.7B), and tCr (Figure 6.7C). Note that the green horizontal line of each plot 
is a literature value of its corresponding metabolite. Averaged fractional 
distributions in the GM and WM are also summarized in Table 6.4. This 
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approach estimated consistent fractional distributions for all metabolites 
that were tested in good agreement with the literature values.
Figure 6.7. Scatter plots of the fractional grey matter (GM) distribution against the measured 
frequency difference between the reconstructed GM and white matter (WM) signals with linear 
regression (solid line) and 95% confidential interval (dotted line) lines for MI (A), total choline 
(tCho) (B), and total creatine (tCr) (C). These were estimated by applying Equation 4 at the single 
subject level. This approach estimated consistent fractional distributions for all metabolites we 
tested, with no obvious dependence on the frequency difference between WM and GM. Note 
that the green horizontal line of each plot is a literature value of its corresponding metabolite. 
Averaged fractional distributions in the GM and WM are also summarized in Table 6.4. 
6.4 Discussion
This study demonstrates the feasibility of reconstructing a spectroscopy 
reference signal by imaging and separating corresponding GM and WM 
lineshapes directly. The frequency difference, which was calculated 
from separated GM and WM signals, demonstrated a level of magnetic 
susceptibility-induced frequency shift similar to that of other imaging 
experiments at 7 T (Duyn et al., 2007; Fukunaga et al., 2010; Haacke et al., 
2005; Lee et al., 2010a; Lee et al., 2010b; Liu et al., 2011; Luo et al., 2010; 
Marques et al., 2009; Maudsley et al., 2016; Ogg et al., 1999; Reichenbach 
et al., 1997; Shmueli et al., 2011; Wu et al., 2009; Yao et al., 2009; Zhong 
et al., 2008. This frequency difference could be clearly distinguished at 
our experimental resolution, and led to discernible effects in the resulting 
spectra. The fact that metabolites may be unequally distributed between 
the GM and WM (Table 6.1) implies that metabolite linewidths and 
frequency shifts may vary slightly depending on the relative GM-to-WM 
distribution and volume fractions of the GM and WM in each voxel. 
The following sections cover the assumptions that we made in the 
present study. First, we selected the NAA peak as a reference to avoid 
several effects that possibly could occur if the water signal was used as 
the reference. It is widely known that the resonance frequency can be 
influenced not only by magnetic susceptibility differences but also by 
temperature and pH changes. The maximal temperature difference  across 
Implications of the magnetic susceptibility difference between 
grey and white matter for single-voxel proton spectroscopy at 7 T
117
6
regions in the brain parenchyma is approximately 2°C, which equals 20 
ppb by temperature dependency of 0.01 ppm/°C for water (Peters et al., 
1998). In addition, Lutz et al. (Lutz et al., 1993) reported that water 
resonance possibly changes with 0.04 ppm/pH unit for 6 < pH < 7.8. We 
could exclude this effect of both temperature and pH differences 
because the water peak was not used as a reference. However, a 
potential frequency shift of NAA was not investigated in the current 
study. Age has also been found to be an important factor that results in 
magnetic susceptibility changes (Li et al., 2014), and this effect was most 
prominently shown in NAA (Maudsley et al., 2017). We neglected this 
effect here because the age range of our subject group exhibited the 
smallest frequency shift in the previous study (Maudsley et al., 2017), and 
furthermore, the age range of our subjects was relatively narrow (31.8 ± 
2.7 years). Besides, as NAAG is predominantly concentrated in WM, it may 
cause a bias of the frequency shift in the WM voxel. However, we did not 
consider this potential effect since NAAG has a far lower concentration 
than NAA. In addition to NAAG, GABA, Gly and GPC showed unequal 
concentrations in the GM and WM, however, concentrations of GABA and 
Gly were relatively much smaller than that of main metabolites: Cr and MI, 
respectively. In addition, GPC exclusively contributed to the 3.2 ppm peak. 
Therefore, the underlying low concentration metabolites are not 
expected to induce a bias in the measurement.
Additional cellular compartmentalization-induced effects (He and 
Yablonskiy, 2009) on individual metabolites were negligible because 
the metabolites studied here are stored in the same compartment. In 
fact, NAA, Cr, and Cho are mainly localized in the intracellular space 
(Nicolay et al., 2001), and the MI in the extracellular compartment is only at 
micromolar concentrations (Fisher et al., 2002). We also did not 
consider possible concentration variations in metabolites between 
regions. However, it has been shown that concentrations of NAA, Cho, 
Cr, and MI are comparable between the two brain regions that signals 
were acquired from: the frontal and parietal lobes (Maudsley et al., 2009).
Differences in the B0 distribution between GM and WM can lead to 
different lineshapes and frequency offsets. The measured frequency 
difference between separated GM and WM signals and B0 field 
inhomogeneity were only moderately linearly related (see Figure 6.6A). 
If for example the frequency differences we found were driven by 
shim quality, where the spatial distribution of GM/WM would then give 
rise to the frequency difference, then we would expect that there would 
be a strong relationship between total linewidth and frequency 
difference. We would also expect that the frequency difference between 
WM  and  GM  would  be  symmetrically distributed about 0 Hz (see Figure 
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6.6B). The fact that we find neither effect is indicative that the 
frequency differences are driven primarily by susceptibility differences 
with a secondary effect of shim.
Using our best available shim quality (i.e. water linewidth of 15.7 ± 1.4 
Hz), by iterated shimming procedures, our finding of 4.9 Hz or 16.5 ppb at 
7 T demonstrated a larger degree of frequency shift between the GM and 
WM compared with another spectroscopy study (Maudsley, et al. 
(Maudsley et al., 2017) reported the maximal values of 4.5 ppb). 
Maudsley et al. (Maudsley et al., 2017) measured frequency differences 
of the GM and WM metabolite signals relative to water, whereas our 
shift was measured from the separated water signals obtained by 
imaging. When we compared the frequency difference between largely 
GM and WM voxels (Figure 6.3) relative to water, as was done by 
Maudley, et al. (Maudsley et al., 2017), the difference was 2.2 Hz or 6.5 
ppb. Even allowing for the tissue fraction of the GM and WM voxels we 
tested here, our finding with this approach is relatively larger than 4.5 
ppb of Maudley, et al. (Maudsley et al., 2017). We cannot eliminate the 
differences between the two studies being a consequence of different 
measurement environments, such as the static field strength, acquisition 
strategy, and measurement method. Our result is in close agreement 
with that of the imaging study performed by Duyn, et al. (Duyn et al., 
2007), which reported that the mean frequency shift between the GM 
and WM was 4.7 Hz or 15.7 ppb at the same field strength that was used 
in our study. 
The calculated GM-to-WM concentration ratios for the selected 
directly measurable metabolites are in close agreement with those in the 
literature (Gasparovic et al., 2009; Kreis, 1997; Maudsley et al., 2009; 
Tal et al., 2012) (see Table 6.4), suggesting that the measured peak 
position can be represented as the sum of the two peaks weighted by their 
GM-to-WM ratio and voxel volume fraction. As three variables,      ,      ,  
and  of Equation 4 that were used to estimate fractional distributions 
in the GM and WM, were acquired at the single subject level, estimated 
fractional distribution values demonstrated consistency, regardless of 
B0 homogeneity for all three metabolites (see Figure 6.7). Thus, for 
the metabolites shown in Table 6.4, this is a feasible approach to assess 
the GM and WM metabolite concentrations in-vivo by combining proton 
spectroscopy with multi-echo imaging. 
One point warranting further discussion is the Cho signal. A 
comprehensive analysis encompassing the metabolic distributions of 
individual components of all choline-containing compounds (Cho, PCh and
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GPC) is, to the best of our knowledge, currently unavailable. Instead, most 
studies quantify this Cho group as a single tCho signal. We assigned a 
chemical shift of 3.2080 ppm to tCho. However, this chemical shift value 
corresponds to that of PCh, and not of free Cho (Govindaraju et al., 2000). 
Our simulated result showed that this 3.2080 ppm peak is mainly 
composed of PCh and GPC, and that Cho is located at a somewhat 
shifted position of 3.1850 ppm. Our finding of tCho distributions of 
42.35%:57.65% in the GM and WM agree fairly well with PCh + GPC 
concentrations in the GM and WM: 40.62%: 59.38% that were reported 
as PCh + GPC by Bank, et al. (Bank et al., 2015), and with the 43.63%: 
56.36% obtained by estimating PCh and GPC separately (Hofmann et al., 
2002) .
Previous studies (Khiat et al., 2000; Miller et al., 1996) have indicated 
that the Cho signal group consists primarily of PCh and GPC, with < 
5% of the signal arising from free Cho itself. Nevertheless, this 3.2 
ppm signal group is often designated as Cho. Given that the Cho 
literature (Kreis, 1997) reported similar absolute concentrations with 
PCh + GPC, with a similar fractional distribution in the GM and WM, it 
appears reasonable that the 3.2 ppm signal of this and other studies, 
is mostly representative of PCh + GPC. In addition, the measured 
linewidth of the 3.2 ppm signal being identical to that of the water 
linewidth supports the notion that PCh and GPC (which have identical 
chemical shifts) mainly contribute this signal; if Cho were present in 
significant concentrations then this would act to broaden the 
linewidth, as its chemical shift is 3.1850 ppm, which should then 
broaden the total line by approximately 4.46 Hz compared to the 
water signal.
The T1 relaxation times of GM and WM have been reported by 
another study (Wright et al., 2008) to be approximately 1900 ms and 
1120 ms, respectively, at 7 T. Ernst angles calculated from these 
T1 values were 14° and 18° for the GM and WM, respectively. We 
used a 20° excitation, which is close to the Ernst angle of both the 
GM and WM. The resulting small differences in the lineshape 
caused by differences in T1-relaxation appeared to be negligible 
(e.g., Figure 6.2). Furthermore, the major goal of this study was to 
investigate the frequency offset, which is independent of this effect.
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Chemical shift displacement error (CSDE) is one typical limitation of SVS. 
However, there is no chemical shift difference between the image voxel 
and the water signal in SVS. Herein, we assumed that the metabolite 
lineshapes are identical to the water lineshape: this study did not 
consider CSDE as a possible source of error. It has been reported that 
the semi-LASER sequence we used in this study demonstrates 
outstanding performance to minimize the CSDE using adiabatic 
refocusing RF pulses with high bandwidths. The semi-LASER sequence 
that we used in this study has a maximal CSDE of 1.7 mm/ppm, which 
corresponds to 8.4% of the spectroscopy voxel. It would, in theory, be 
possible to extend the imaging volume so that the CSDE for each 
metabolite could be accounted for: this would come at the expense of 
some increase in the scanning duration.
In conclusion, this study identified the effects of a susceptibility 
difference on the GM and WM signal lineshapes and frequencies for 
single voxel spectroscopy. We found a level of frequency shift similar to 
that reported in other imaging studies. This leads to detectable increases 
in linewidth, an effect that will increase with further increases in the static 
field strength. The acquisition of additional information via imaging 
made it possible to estimate the relative metabolic distribution in GM 
and WM. This may offer a potential method for assessing metabolite 
concentrations in GM/WM while accounting for partial volume effects.
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7.1 Summary
GABA is the main inhibitory neuro-transmitter; hence, it is important in 
behavior, cognition, and the body’s response to stress in the human brain. 
NMR spectroscopy is a valuable modality to monitor GABA levels non-
invasively. Even though ultrahigh static B0 field and multichannel phased 
array receiver along with a specially designed GABA acquisition method 
such as the GABA editing technique improve the performance of the 
GABA detection, it is still difficult to accurately detect GABA owing to its 
low concentration. This thesis investigated methodological approaches to 
improve the sensitivity and reproducibility of the acquisition, and increase 
the accuracy and precision of the quantification for GABA at 7 T.
In Chapter 3, we compared two representative GABA acquisition 
methods, the standard acquisition and the GABA editing methods using 
the simultaneous acquisition of two methods using an interleaved 
sequence for precise comparison. GABA editing method suffers from one 
technical limitation; the edited GABA signal is contaminated by the co-
edited MM. In this study, we found that the ability to reliably measure the 
GABA resonance at 2.28 ppm leads to the accurate estimates of GABA 
concentration without MM contamination. After compensating tissue 
volume and TE variations, two methods showed comparable accuracy 
with LCModel analysis. In addition, estimated fractional GABA 
concentrations in the GM and WM showed good agreement with 
literature values. Our proposed approach, that used the 2.28 GABA 
resonance, estimates pure GABA accurately without MM contamination. 
Our findings also confirmed that GABA is heavily concentrated in GM. 
Therefore, regional GM volume is an important contributor to the GABA 
concentration variation measured. However, the GABA editing method 
was superior in terms of precision. 
The study presented in Chapter 4, assessed the coil combination 
techniques for GABA detection. The multichannel phased-array receiver, 
which normally has 16 or 32 channels, is standard hardware in the modern 
MR scanner. The multichannel acquisition makes it possible to improve 
the SNR of the acquired signal for single voxel spectroscopy together 
with the optimized coil weighting strategy. However, the widely-used 
signal weighting method is not optimal for the GABA spectroscopy. This 
chapter compared previously proposed weighting methods and proposed 
modified methods that exclude lower SNR coil data to maximize SNR. In 
this chapter, we assessed the coil combination strategies in terms of not 
only the spectral SNR improvement but also the  spectral  fitting precision 
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improvement. With the proposed coil weighting approach, the SN2R 
weighting method provided reliable GABA quantification by decreasing 
the spectralfitting error. Judging from the spectral fitting precision, 
SN2R weighting with a limited number of coils is an optimal coil 
combination method for both representative GABA acquisition 
approaches. In addition, optimized selective coil weighted combination 
does not require a dominant signal in the time domain; therefore, we 
can use strong water suppression, which can eliminate baseline 
distortion and spurious signals and lead to reliable and consistent 
detection of low concentration metabolites.
Favorable B0 homogeneity is considered to be a critical prerequisite to 
obtain good results in GABA spectroscopy because it directly affects the 
spectral lineshape. An inhomogeneous B0 field leads to not only SNR 
reduction but also broadens the linewidth and causes it to deviate 
from a Lorentzian form. However, shimming is not invariably successful. 
Most quantification algorithms assume that the spectral lineshape can be 
represented using a Lorentzian function. If the experimental lineshape is 
apparently different from the ideal form, it is difficult to expect an accurate 
quantification result. Even if quantification algorithms contain correction 
steps, it is challenging to precisely correct the distorted lineshapes 
using regular mathematical algorithms. In addition, while correcting a 
resultant spectrum, there is a risk of losing critical spectral information and 
compromising the SNR. In Chapter 5, we suggested one potential solution 
that uses the water lineshape fitting model for spectral fitting. This study 
demonstrated the effect of linewidth on the estimates of metabolite 
concentration when using the realistic spectral model fitting. For most 
metabolites, the water lineshape fitting method estimated more 
consistent metabolite concentration levels with smaller variations 
compared with the conventional fitting method, for the different field 
homogeneity conditions tested. However, the conventional fitting 
method had numerically lower values of the CRLB parameter. 
Although this water lineshape approach is less precise compared with 
the conventional approach, considering the fundamental objective of 
proton spectroscopy, the water lineshape fitting approach is superior 
to the conventional approach in terms of accuracy.
In Chapter 6, we investigated one confound that has, hitherto, been 
largely ignored by the spectroscopy community: that of a potential 
frequency shift caused by magnetic susceptibility differences between 
the grey and white matter. Imaging experiments found approximately 5 - 
10  Hz  frequency  shift  between  white matter and grey matter. This study 
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demonstrated the feasibility of reconstructing a spectroscopy reference 
signal by imaging and separating corresponding GM and WM lineshapes 
directly. The frequency difference, which was calculated from separated 
GM and WM signals, found a level of magnetic susceptibility-induced 
frequency shift similar to that of other imaging experiments at 7 T. In 
addition to the frequency shift, we also found linewidth differences 
between the two tissue types in single-voxel spectroscopy. These findings 
explain the differences in the chemical shift and the linewidth of 
metabolites caused by the differing distributions between the grey and 
white matter. In addition, we demonstrated its use in quantifying the 
fractional distribution of metabolites in the grey and white matter. The 
calculated GM-to-WM concentration ratios for the selected directly 
measurable metabolites are in close agreement with those in the 
literature, suggesting that the measured peak position can be 
represented as the sum of the two peaks weighted by their GM-to-WM 
ratio and voxel volume fraction. The acquisition of additional information 
via imaging made it possible to estimate the relative metabolic 
distribution in GW and WM. This may offer a potential method for 
assessing metabolite concentrations in GM/WM while accounting for 
partial volume effects.
7.2 Future direction
The research work presented in this thesis seems to have raised more 
questions that it has answered. There are several possible 
research directions that should be pursued.
The choices of TEs of the interleaved sequence used in this study were 80 
ms for the GABA-editing and 38 ms for the non-editing approaches. These 
TEs are slightly longer than expected values because an increased number 
of gradient pulses were required to have sufficient gradient 
performance. Ideally, 68 ms is a theoretical TE the GABA-editing method 
and shorter TE is better for the non-editing acquisition. Through the 
implementation of the acquisition sequences, it should be investigated 
whether both methods have similar accuracy and precision for the 
GABA detection when the shorter TEs are used. 
Besides the GABA editing method, other spectral editing approaches such 
as lactate (Sotak and Freeman, 1988), glutathione (Terpstra et al., 
2003) and 2-hydroxyglutarate (2HG)(Choi et al., 2012b) also suffer from 
the co-edited signals (e.g. co-edited NAA for GSH-editing, co-edited 
Glx to for 2HG-editing).  As  we  showed  in Chapter 2, the spectral fitting 
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approach that uses all resonance groups potentially solves the co-edited 
signal problem. Therefore, it should be investigated with our LCModel 
analysis approach in combination with the spectral acquisition at the 
ultrahigh field, if it is possible to solve the co-edited signal problem for 
other metabolite editing strategies.  
The proposed coil combination method used in this thesis provides 
improved SNR and spectral fitting precision. This work focused on the 
single voxel GABA spectroscopy. Once expanded the range of its usage, 
this technique could be useful for magnetic resonance spectroscopy 
imaging (MRSI), where SNR is a major concern. By moving to other 
metabolites, the optimal coil combination method could be further 
investigated for each metabolite.
The original motivation for the development of realistic spectral 
fitting models in Chapter 5 was to accurately measure metabolite 
concentration. In Chapter 5, we showed that the realistic fitting model, 
which considered the lineshape modification by the B0 field 
inhomogeneity, improved the accuracy in quantifying the metabolite 
concentration. Furthermore, in Chapter 6, we also found that magnetic 
susceptibility differences between the tissue types slightly modify the 
spectral lineshape and chemical shift. In future work, modifying the 
lineshape and quantifying metabolite more accurately, not only B0 
inhomogeneity but also magnetic susceptibility differences, should be 
considered. 
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Samenvatting
GABA is de voornaamste inhibiterende neurotransmitter. Als gevolg is het 
belangrijk voor gedrag, cognitie en de reactie van het lichaam op stress in 
het mensenbrein. NMR-spectroscopie is een waardevolle manier om 
hoeveelheden GABA niet-invasief te meten. Hoewel ultrahoge statische 
B0 velden en zogenaamde multichannel phased array ontvangers samen 
met speciaal ontwikkelde GABA-acquisitie methodes zoals GABA-
bewerking technieken de kwaliteit van GABA-detectie verbeteren, is het 
nog steeds moeilijk om GABA correct te meten door zijn lage 
concentraties. Deze thesis onderzocht methodologische toepassingen om 
de gevoeligheid en reproduceerbaarheid van de meting te verbeteren en 
de correctheid en precisie van GABA-kwantificatie bij 7T te verhogen.
In Hoofdstuk 1 worden de natuurkundige achtergrond en principes van 
NMR-spectroscopie uitgelegd. Hoofdstuk 2 introduceert de voornaamste 
meet- en kwantificatiemethodes die in deze thesis gebruikt worden om 
GABA te detecteren. 
In Hoofdstuk 3 vergelijken we twee veelvoorkomende GABA 
meetmethodes: de standaard PRESS meting en de GABA-bewerking 
methode (MEGA). Wij maken gebruik van de gelijktijdige meting van de 
twee methodes aan de hand van een gewoven protocol voor nauwkeurige 
vergelijking. GABA-bewerking lijdt aan één technische beperking: het 
gemonteerde GABA-signaal is vervuild door de meegemonteerde 
macromoleculen. In dit onderzoek hebben we gezien dat het consistent 
kunnen meten van van de GABA-resonantie bij 2,28 ppm leidt tot correcte 
schattingen van GABA-concentraties zonder MM-vervuilingen. Na te 
hebben gecorrigeerd voor weefsels en TE variaties lieten twee methodes 
vergelijkbare nauwkeurigheid zien met een LCModel analyse. Daarnaast 
toonden geschatte GABA-concentratie fracties in de grijze en witte 
massa’s overeenstemming met de waardes uit de literatuur. De methode 
die wij voorstellen, waarbij gebruik gemaakt wordt van 2,28 GABA-
resonantie, schat pure GABA nauwkeurig zonder MM-vervuilingen. Onze 
bevindingen bevestigden ook dat GABA sterk geconcentreerd is in grijze 
massa. Daarom levert plaatselijk grijze massa volume een belangrijke 
bijdrage aan de gemeten GABA-concentratie variaties. 
Het onderzoek dat in Hoofdstuk 4 gepresenteerd wordt, toetste de 
spoelcombinatie technieken voor GABA-detectie. De zogenaamde 
multichannel phased-array ontvangers, die normaliter 16 tot 32 kanalen 
bevatten,  is  standaarduitrusting  bij  moderne  MR-Scanners.  Meten  met
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een veelvoud van kanalen, samen met een geoptimaliseerde spoelweging 
strategie, maakt het mogelijk om de SNR van het gemeten signaal per 
voxel spectroscopie te verbeteren. Echter is de meest-gebruikte 
signaalwegingsmethode niet optimaal voor GABA-spectroscopie. Dit 
hoofdstuk vergeleek eerder-voorgestelde wegingsmethodes en droeg 
een aangepaste methode voor die data afkomstig van spoelen met een 
lage SNR negeert om SNR te maximaliseren. In dit hoofdstuk toetsten we 
de spoelcombinatiestrategieën niet alleen op basis van de verbetering in 
de spectrale SNR, maar ook op basis van de verbetering in spectrale 
fitting-precisie. Met de voorgestelde spoelwegingsmethode gaf de SN2R 
wegingsmethode betrouwbare GABA-kwantificaties door de spectrale 
fitting-foutmarge te verkleinen. Kijkende naar de spectrale fitting-
precisie blijkt dat SN2R-weging met een beperkt aantal spoelen de 
optimale spoelcombinatiemethode voor beide GABA-meetmethodes uit 
hoofdstuk 3 is. Daarbij komt dat geoptimaliseerde, selectieve 
spoelwegingscombinatie geen dominant signaal vereist in het 
tijdsdomein. Daarom kunnen we sterke wateronderdrukking gebruiken, 
wat vervormingen in de basislijn en valse signalen elimineert en leidt tot 
betrouwbare en consistente detectie van lage concentratie metabolieten.
Gunstige B0 homogeniteit wordt gezien als cruciaal om goede resultaten 
in GABA-spectroscopie te behalen, omdat het direct invloed heeft op de 
spectrale lijncontour. Een inhomogeen B0 veld leidt niet alleen tot een 
verlaagde SNR, maar het verbreedt ook de lijnbreedte en zorgt ervoor dat 
deze afwijkt van de Lorentziaanse vorm. Veldcorrecties zijn echter niet 
altijd succesvol. De meeste kwantificatiealgoritmes nemen de aanname 
dat de spectrale lijncontour vertegenwoordigd kan worden met een 
Lorentziaanse functie. Als de experimentele lijncontour blijkt af te wijken 
van de ideale vorm, dan is het irreëel een correct kwantificatieresultaat te 
verwachten. Zelfs wanneer kwantificatiealgoritmes een correctiestap 
meenemen, dan blijft het uitdagend om de vervormde lijncontouren goed 
te corrigeren met alledaagse wiskundige algoritmes. Daarnaast bestaat 
tijdens het corrigeren van een resulterend spectrum het risico dat cruciale 
spectrale informatie verloren gaat en dat de SNR in het geding komt. In 
Hoofdstuk 5 stellen we één potentiële oplossing voor die gebruik maakt 
van het fittingmodel van het waterlijncontour voor spectrale fitting. Dit 
onderzoek demonstreerde wat het effect is van de lijnbreedte op de 
geschatte waardes van metabolietconcentraties wanneer gebruik wordt 
gemaakt van de realistische spectrale modelfitting. Voor de meeste 
metabolieten gaf de waterlijncontourfittingmethode een meer 
consistente  schatting  van  metabolietconcentratieniveaus  met   kleinere 
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variaties vergeleken met de gevestigde fittingmethode, onder 
verschillende veldinhomogeniteiten die zijn getest. De gevestigde 
fittingmethode had echter numeriek lagere CRLB-waardes. Hoewel deze 
waterlijncontourmethode minder precies is in vergelijking met de 
gevestigde manier, is de waterlijncontourfittingmethode, met de 
doelen die ten grondslag liggen aan proton spectroscopie in gedachte, 
superieur aan de gevestigde methode op het gebied van correctheid. 
In Hoofdstuk 6 onderzochten we één beïnvloedende factor die, tot nu 
toe, merendeels is genegeerd door de spectroscopiegemeenschap: de 
potentiële frequentieverschuiving veroorzaakt door magnetische 
susceptibiliteitsverschillen tussen grijze en witte massa. 
Imagingexperimenten lieten een frequentieverschuiving zien van 
ongeveer 5 – 10 Hz tussen grijze en witte massa. Dit onderzoek toonde 
dat het haalbaar is om een spectroscopisch referentiesignaal te 
reconstrueren door corresponderende grijze- en witte-
massalijncontouren direct in beeld te brengen en te scheiden. Het 
frequentieverschil, welk berekend was uit gescheiden grijze- en witte-
massasignalen, vertoonde een door magnetische-susceptibiliteit-
veroorzaakt frequentieverschilniveau vergelijkbaar met dat van andere 
imaging experimenten bij 7T. Naast het frequentieverschil zagen we ook 
lijnbreedteverschillen tussen deze twee weefsels in spectroscopie van 
één voxel. Deze bevindingen verklaren de verschillen in de chemische 
verschuiving en de lijnbreedte van metabolieten die veroorzaakt worden 
door de verschillende verdelingen tussen grijze en witte massa. 
Daarnaast demonstreerden we de toepassing hiervan bij het 
kwantificeren van de fractionele distributies van metabolieten in de grijze 
en witte massa. De berekende grijze-tot-witte-
massaconcentratieverhoudingen voor de geselecteerde, direct-meetbare 
metabolieten komen nauw overeen zoals ze in de literatuur gevonden 
kunnen worden, wat suggereert dat de gemeten piekpositie 
gerepresenteerd kan worden als de som van de twee pieken, gewogen 
aan de hand van de grijze-tot-witte-massaverhouding en de 
voxelgroottefractie. De meting van verdere informatie via imaging stond 
het toe om de relatieve metabolietdistributie in grijze en witte massa te 
schatten. Dit kan een potentiële methode bieden om 
metabolietconcentraties in grijze en witte massa te beoordelen terwijl er 
rekening gehouden wordt met deelvolume-effecten.
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